Dry age-related macular degeneration (includes geographic atrophy)

DRY_AMD

There were some mistakes of the ICD code for dry-AMD (nonexudative macular degeneration), the right might as follows: ICD-10 code: H35.31 ICD-9 code: 3625.1

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions not DRY_AMD_EARLY	519810
3. Check pre-conditions, main-only, mode, registry filters Pre-conditions: EVENT_AGE>=50 Registry filters: Hospital discharge: ICD-10 — H35.30 Hospital discharge: ICD-9 — 3625A Cause of death: ICD-10 — H35.30 Cause of death: ICD-9 — 3625A 2 out of 7 registries used, show all original rules.	9803
4. Check minimum number of events None	9803
5. Include endpoints None	9803
6. Filter based on genotype QC (FinnGen only)	9533

Control definitions (FinnGen only)

Control exclude: H7_RETINOPATHYDIAB, H7_RETINASEPAR, MACULA_NAS, H7_GLAUCPRIMOPEN, H7_GLAUCCLOSEPRIM, H7_GLAUCSECTRAUMA, H7_GLAUCSECINFLAM, H7_GLAUCSECDISEASE, H7_GLAUCSECDRUG, H7_GLAUCNAS
Control pre-conditions: DEATH_AGE>=50
Control conditions: not DRY_AMD_EARLY

Extra metadata

Level in the ICD hierarchy: 5
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H35
Name in latin: Degeneratio maculae senilis atrophica

NAME	DRY_AMD
CONTROL_EXCLUDE	H7_RETINOPATHYDIAB\|H7_RETINASEPAR\|MACULA_NAS\|H7_GLAUCPRIMOPEN\|H7_GLAUCCLOSEPRIM\|H7_GLAUCSECTRAUMA\|H7_GLAUCSECINFLAM\|H7_GLAUCSECDISEASE\|H7_GLAUCSECDRUG\|H7_GLAUCNAS
CONTROL_PRECONDITIONS	DEATH_AGE>=50
CONTROL_CONDITIONS	!DRY_AMD_EARLY
SEX
INCLUDE
PRE_CONDITIONS	EVENT_AGE>=50
CONDITIONS	!DRY_AMD_EARLY
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H3530
HD_ICD_9	3625A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H3530
COD_ICD_9	3625A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Dry age-related macular degeneration (includes geographic atrophy) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	76411	48970	27076
Only index persons	68221	44279	23942
Unadjusted period prevalence (%)
Whole population	1.17	1.40	0.76
Only index persons	1.38	1.63	0.91
Median age at first event (years)
Whole population	79.61	80.34	78.29
Only index persons	79.38	80.14	77.98

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9533	5227	4306
Unadjusted period prevalence (%)	1.91	1.85	1.97
Median age at first event (years)	76.87	76.91	76.83

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9802: Matched controls
92126

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

13.7

307.7

371

263

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

21.9

307.7

3278

2066

H25.1

ICD-10 Finland

Senile nuclear cataract

2.8

307.7

5520

28706

XCH00

NOMESCO Finland

Eye pressure measurement

5.5

307.7

886

1640

Z96.1

ICD-10 Finland

Presence of intraocular lens

4.9

307.7

3722

10167

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

8.0

307.7

1643

2275

S01EA05

ATC

brimonidine; ophthalmic

13.6

307.7

329

234

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

89.1

307.7

409

S01EE01

ATC

latanoprost; ophthalmic

5.5

307.7

887

1629

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

120.3

307.7

875

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

53099.3

307.7

9773

581

H40.11

ICD-10 Finland

Low pressure glaucoma

33.2

307.7

268

XCD20

NOMESCO Finland

Photoangiography of eye

14.0

307.7

612

436

XCK00

NOMESCO Finland

Perimetry

4.5

307.7

885

2001

XCW99

NOMESCO Finland

Other investigative procedure of eye

6.9

307.7

2690

4806

CJB10

NOMESCO Finland

Laser discission of secondary cataract

3.4

307.7

1996

6530

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

2.3

307.7

4999

28449

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

3.5

307.7

6589

33933

114

Kela drug reimbursment

Glaucoma

6.0

307.7

1253

2212

S01EC04

ATC

brinzolamide; ophthalmic

8.9

307.7

503

559

S01ED51

ATC

timolol, combinations; ophthalmic

5.9

307.7

1058

1857

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

17.3

307.7

430

243

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

15.0

307.7

2433

1984

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

55.4

307.7

717

131

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.5

307.7

2540

8342

H26.4

ICD-10 Finland

After-cataract

3.1

307.7

2265

8121

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

9.0

307.7

2731

3785

XCK10

NOMESCO Finland

Photography of fundus of eye

4.3

307.7

1810

4563

H25.8

ICD-10 Finland

Other senile cataract

2.6

297.2

2278

9754

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.2

290.7

5304

32587

XCW10

NOMESCO Finland

Assessment of vision

10.3

271.7

317

299

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

4.4

253.0

671

1497

CM2S4

NOMESCO Finland

Follow-up photography of age-related macular degeneration lesions

15.5

249.7

226

140

CKW99

NOMESCO Finland

Other operation on choroid, vitreous body and retina

14.9

245.9

227

146

H25.0

ICD-10 Finland

Senile incipient cataract

3.0

245.4

1199

4029

CK2M4

NOMESCO Finland

Macular light layer imaging (OCT)

14.1

241.2

230

157

CM2X4

NOMESCO Finland

Follow-up OCT of age-related macular degeneration lesions

10.3

231.3

268

250

ZXA10

NOMESCO Finland

Bilateral

2.2

222.6

2540

12725

H40.9

ICD-10 Finland

Glaucoma, unspecified

17.6

222.4

189

103

S01ED01

ATC

timolol; ophthalmic

5.1

207.7

459

878

H35.7

ICD-10 Finland

Separation of retinal layers

953.5

199.0

199

S01EE05

ATC

tafluprost; ophthalmic

5.6

198.3

391

674

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

7.2

196.8

304

408

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

26.7

195.2

140

CHD00

NOMESCO Finland

Laser trabeculoplasty

20.3

192.1

153

S01EX03, ,

ATC

7.3

188.1

286

377

H40.0

ICD-10 Finland

Glaucoma suspect

3.0

187.4

889

2920

S01EC54

ATC

brinzolamide, combinations; ophthalmic

16.3

183.9

162

S01EE03

ATC

bimatoprost; ophthalmic

7.9

173.1

245

297

S01EC03

ATC

dorzolamide; ophthalmic

10.6

167.9

190

171

S01EC01

ATC

acetazolamide; systemic

7.4

167.1

251

326

CK2Y4

NOMESCO Finland

OCT video recording of ocular fundus

16.4

163.1

143

H36.00

ICD-10 Finland

Diabetic background retinopathy

25.6

159.6

116

N02BE01

ATC

paracetamol; systemic, rectal

2.4

158.7

8709

70971

H36.01

ICD-10 Finland

Diabetic maculopathy

47.9

156.6

WX140

NOMESCO Finland

Parabulbar anesthesy

3.3

152.0

616

1836

A98

ICPC

Health maint/preventive medicine

2.3

149.0

8655

70757

S01EE04

ATC

travoprost; ophthalmic

6.4

148.9

254

379

CK9F4

NOMESCO Finland

Fluorescein angiography (FAG) of choroid and retina

11.8

148.7

157

127

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

4.9

148.4

339

666

H3601, E113,

ICD-10 Finland

+∞

146.9

144

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

14.3

145.7

137

H3600, E113,

ICD-10 Finland

+∞

137.7

135

CS494

NOMESCO Finland

Other visual field testing

5.4

137.4

280

497

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

7.4

137.4

206

267

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

4.8

136.1

323

655

ZX198

NOMESCO Finland

Other local administration

6.7

127.4

210

302

SPAT1263

SPAT

Sampling

1.7

125.9

4225

28744

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

5.9

121.8

227

370

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

121.0

1329

6404

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.9

113.6

1830

10056

H35.6

ICD-10 Finland

Retinal haemorrhage

7.8

113.2

161

196

H35.9

ICD-10 Finland

Retinal disorder, unspecified

10.2

108.1

125

116

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

1006.2

106.0

106

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

30.0

105.7

SPAT1312

SPAT

General health counselling

1.7

104.6

2967

19095

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

102.2

7071

56226

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

102.1

4217

29698

Z3229

NOMESCO Finland

Other healthcare associate professional

2.1

101.0

1033

4826

SPAT1301

SPAT

No procedures

1.6

100.6

3490

23559

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.7

98.1

2524

15788

J01DB01

ATC

cefalexin; oral

1.7

94.4

7379

59743

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

93.4

4964

36747

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

93.1

3639

25142

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.7

92.8

2444

15344

SPAT1310

SPAT

Counselling related to known health issue

1.6

92.2

3055

20296

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

4.3

90.7

240

531

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

90.2

3039

20248

H53.1

ICD-10 Finland

Subjective visual disturbances

2.4

88.5

677

2799

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.6

87.2

297

789

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

4.2

86.2

237

540

A02BC02

ATC

pantoprazole; systemic

1.6

85.7

6534

51868

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

84.6

1021

5054

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

82.3

5563

42845

CK9G4

NOMESCO Finland

Iridocyanine green angiography (ICGA) of choroid and retina

12.7

81.7

AA1AD

NOMESCO Finland

CT of head and brain

1.5

81.5

3251

22390

H40

ICD-10 Finland

Glaucoma

6.5

74.2

125

184

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

72.3

2025

12791

CHD65

NOMESCO Finland

Nonpenetrating glaucoma surgery

+∞

72.3

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

72.1

3018

20874

SPAT1325

SPAT

Vaccination

1.5

71.6

3818

27738

S01ED02

ATC

betaxolol; ophthalmic

7.2

71.1

108

142

SPAT1153

SPAT

Removal of sutures

1.5

69.9

3171

22272

H40.22

ICD-10 Finland

Chronic glaucoma with closed ventricular angle

230.4

69.6

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

68.9

2008

12787

C08CA01

ATC

amlodipine; oral

1.5

68.1

4439

33423

XCD10

NOMESCO Finland

Electrophysiological examination of eye

3.0

66.7

315

1023

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

66.5

3071

21594

R42

ICD-10 Finland

Dizziness and giddiness

1.5

66.3

2636

17971

ZXA05

NOMESCO Finland

Left side

1.5

65.4

2678

18359

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

3.7

65.2

211

541

M54.5

ICD-10 Finland

Low back pain

1.5

64.5

2841

19761

S01BC05

ATC

ketorolac; ophthalmic

2.2

64.2

568

2491

TCK00

NOMESCO Finland

Photosensitisation of choroid and retina

14.2

63.6

S01EB01

ATC

pilocarpine; ophthalmic

8.2

63.4

M79.6

ICD-10 Finland

Pain in limb

1.5

63.3

3556

25922

S18

ICPC

Laceration/cut

1.4

61.7

4311

32664

CKC10

NOMESCO Finland

Local photocoagulation of retina

3.8

61.6

196

497

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

61.3

2443

16613

S01BC03

ATC

diclofenac; ophthalmic

3.1

61.2

268

833

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

4.2

60.9

167

380

L28

ICPC

Limited function/disability (L)

1.5

60.1

2280

15335

SPAT1262

SPAT

Handing over of treatment supplies

1.6

59.3

1805

11560

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

59.0

5081

39827

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

59.0

1641

10289

CHC05

NOMESCO Finland

Iridotomy

4.6

58.6

142

293

SPAT1260

SPAT

Consultation of another employee

1.6

58.6

1761

11242

H3603, E113,

ICD-10 Finland

+∞

58.0

CKC12

NOMESCO Finland

Photocoagulation of retina

2.8

57.8

300

1026

H35.37

ICD-10 Finland

Macular holes

3.6

57.3

191

500

CHF05

NOMESCO Finland

Transscleral laser coagulation of ciliary body

189.1

56.6

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

56.2

2424

16700

H35.0

ICD-10 Finland

Background retinopathy and retinal vascular changes

7.9

56.2

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

55.9

3509

25938

H34.8

ICD-10 Finland

Other retinal vascular occlusions

2.8

54.8

286

981

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

54.1

2834

20242

E0000UV, ,

ATC

1.4

54.0

3561

26509

SPAT1254

SPAT

Administration of medicine

1.5

53.6

1769

11509

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

53.6

3860

29166

H43.1

ICD-10 Finland

Vitreous haemorrhage

3.1

53.2

228

700

F05

ICPC

Visual disturbance other

2.5

52.6

335

1270

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

52.5

1874

12394

H35

ICD-10 Finland

Other retinal disorders

12.9

52.3

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

5.8

52.2

161

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

52.0

2266

15606

ZXA00

NOMESCO Finland

Right side

1.4

51.5

2780

19927

CHD15

NOMESCO Finland

Trabeculectomy and iridectomy

170.1

50.6

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

50.5

1589

10216

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

50.4

708

3666

SPAT1229

SPAT

Assessment of need for aid

1.7

50.1

1031

5973

R06.0

ICD-10 Finland

Dyspnoea

1.4

50.1

2820

20350

XCH05

NOMESCO Finland

Eye pressure longterm registration

7.4

49.8

CA1ME

NOMESCO Finland

Ultrasound oculometry

4.7

49.7

117

236

H81

ICPC

Excessive ear wax

1.5

48.6

1938

13086

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

48.5

2227

15460

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.8

48.1

843

4667

C07AB07

ATC

bisoprolol; oral

1.4

47.6

5545

44959

T90

ICPC

Diabetes non-insulin dependent

1.4

47.5

2336

16417

R53

ICD-10 Finland

Malaise and fatigue

1.4

47.4

2391

16881

SPAT1053

SPAT

Memory test

1.5

47.1

2173

15087

L03

ICPC

Low back symptom/complaint

1.5

47.0

2195

15272

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

46.9

1380

8725

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

46.8

4432

34753

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

46.7

3108

23022

SPAT1216

SPAT

Assessment of functional ability

1.5

46.7

2018

13830

H35.5

ICD-10 Finland

Hereditary retinal dystrophy

8.4

46.4

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

11.2

46.2

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

46.0

3146

23395

1LA05, ,

NOMESCO Finland

5.5

46.0

154

3651A

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA SIMPLEX (AVOKULMA)]

+∞

45.8

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.5

45.4

294

1124

N03AX16

ATC

[U] pregabalin

1.4

44.8

2100

14603

C03CA01

ATC

furosemide; systemic

1.4

44.7

4363

34287

UDC00

NOMESCO Finland

Ear microscopy

1.8

44.4

706

3795

H35.36

ICD-10 Finland

Macular cyst

4.9

44.2

100

195

A04

ICPC

Weakness/tiredness general

1.5

44.1

1542

10114

UJF32

NOMESCO Finland

Coloscopy

1.4

43.9

2638

19162

H35.8

ICD-10 Finland

Other specified retinal disorders

6.1

43.3

117

H40.20

ICD-10 Finland

Acute glaucoma with closed ventricular angle

+∞

42.7

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

42.3

3610

27713

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

42.1

1982

13772

SPAT1043

SPAT

Audiometry

1.6

41.9

1244

7864

N06AX11

ATC

mirtazapine; oral

1.4

41.7

2917

21693

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.9

41.1

589

3065

S01EA03

ATC

apraclonidine; ophthalmic

4.4

40.8

104

224

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

40.4

2638

19376

SPAT1097

SPAT

Recording of ECG

1.5

40.2

1571

10518

H02AB06

ATC

prednisolone; systemic

1.3

40.1

4359

34597

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

39.7

3165

23982

J01CA04

ATC

amoxicillin; systemic

1.4

39.7

6666

56316

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

39.6

1271

8168

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

39.5

419

1967

A28

ICPC

Limited function/disability NOS

1.4

39.5

2375

17198

J01MA02

ATC

ciprofloxacin; systemic

1.3

39.3

3801

29634

CHD35

NOMESCO Finland

Laser goniopuncture

375.4

39.1

H54.1

ICD-10 Finland

Severe visual impairment, binocular

9.9

38.9

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

38.8

1402

9237

3625A

ICD-9 Finland

Other retinal disorders, Degeneration of macula and posterior pole[DEGENERATIO MACULAE NONEXSUDATIVA]

+∞

38.7

H3600, E103,

ICD-10 Finland

+∞

38.7

B01AF02

ATC

apixaban; oral

1.5

38.6

1619

10982

H54.7

ICD-10 Finland

Unspecified visual loss

4.5

38.4

200

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

38.2

972

5924

P20

ICPC

Memory disturbance

1.4

37.6

1963

13858

L17

ICPC

Foot/toe symptom/complaint

1.4

37.1

2512

18515

H91.1

ICD-10 Finland

Presbycusis

1.6

36.6

995

6154

A10AB05

ATC

insulin aspart; parenteral

1.8

36.5

622

3410

H13

ICPC

Plugged feeling ear

1.4

36.1

1995

14206

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

179.3

35.9

CKD94

NOMESCO Finland

Combined vitrectomy and procedure on lens through pars plana

3.0

35.6

159

501

A10AE04

ATC

insulin glargine; parenteral

1.6

35.4

815

4841

CK2P4

NOMESCO Finland

Optic nerve head light layer imaging (OCT)

9.4

35.3

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

34.8

2846

21548

H02

ICPC

Hearing complaint

1.4

34.7

1564

10733

R51.80

ICD-10 Finland

Headache

1.6

34.7

998

6251

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

5.0

34.5

145

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

34.3

2833

21470

H54.5

ICD-10 Finland

Severe visual impairment, monocular

5.2

34.1

129

WZC00, ,

SPAT

1.7

33.5

718

4188

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

33.4

941

5862

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

33.3

2488

18562

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

33.2

1693

11872

D07AC01

ATC

betamethasone; topical

1.3

33.0

2994

22975

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

2.3

32.9

251

1034

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.2

32.7

299

1327

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

5.0

32.7

134

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

32.5

3099

23933

J01AA02

ATC

doxycycline; systemic

1.3

32.4

6839

58644

H40.1

ICD-10 Finland

Primary open-angle glaucoma

13.1

32.4

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

32.3

1124

7328

N03AX12

ATC

[U] gabapentin; oral

1.4

32.2

1370

9290

C10AA01

ATC

simvastatin; oral

1.3

32.2

5000

41167

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

32.2

1549

10746

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.8

31.8

244

M48.0

ICD-10 Finland

Spinal stenosis

1.4

31.8

1404

9588

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.6

31.7

892

5553

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.7

31.6

635

3639

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

31.6

2733

20801

Z01.2

ICD-10 Finland

Dental examination

1.3

31.6

2872

22013

XKD00

NOMESCO Finland

Uroflowmetry

1.4

31.6

1671

11781

F28

ICPC

Limited function/disability (F)

4.0

30.9

211

F29

ICPC

Eye symptom/complaint other

1.6

30.7

722

4308

S01EA02

ATC

dipivefrine; ophthalmic

10.3

30.5

37510

ICD-8 Finland

Glaucoma, Chronicum simplex

+∞

30.5

K02.1

ICD-10 Finland

Caries of dentine

1.3

30.5

3711

29539

WX199

NOMESCO Finland

Other local analgesia

2.0

30.4

353

1713

C10AA05

ATC

atorvastatin; oral

1.3

30.1

4213

34115

N30.0

ICD-10 Finland

Acute cystitis

1.4

30.1

1571

11041

SFA10

NOMESCO Finland

One-surface restoration

1.3

29.7

3616

28756

R03AC02

ATC

salbutamol; inhalant

1.3

29.5

4244

34458

SPAT1234

SPAT

Support of social functional capacity

1.6

29.5

681

4045

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

29.4

646

3789

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

29.4

2126

15733

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.5

29.2

899

5707

R02

ICPC

Shortness of breath/dyspnoea

1.4

28.9

1269

8642

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

28.9

2001

14704

CS2P4

NOMESCO Finland

Optic nerve head imaging

4.9

28.9

123

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

28.6

3670

29336

H3603, E103,

ICD-10 Finland

+∞

28.5

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

28.4

1850

13463

F38

ICPC

Eye, Other laboratory test NEC

2.9

28.3

132

427

ZXE00

NOMESCO Finland

One hour or less

1.3

28.2

3216

25314

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

28.1

1337

9234

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

28.1

1807

13121

CHD99

NOMESCO Finland

Other filtering operation

275.1

28.1

C09CA01

ATC

losartan; oral

1.3

28.0

2546

19443

A02BC05

ATC

esomeprazole; systemic

1.3

27.7

3414

27128

SPAT1211

SPAT

Application of soft bandage

1.5

27.6

823

5187

UKC02

NOMESCO Finland

Cystoscopy

1.4

27.5

1769

12845

H44.2

ICD-10 Finland

Degenerative myopia

8.5

27.3

D07AC13

ATC

mometasone; topical

1.3

27.3

2275

17160

SFA20

NOMESCO Finland

Two-surface restoration

1.3

27.2

3590

28746

H40.8

ICD-10 Finland

Other glaucoma

36.7

27.1

SPAT1304

SPAT

Counselling and guidance related to ageing

1.5

27.1

1040

6903

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

26.9

3665

29444

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

26.9

1006

6642

H53.0

ICD-10 Finland

Amblyopia ex anopsia

4.0

26.9

182

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.6

26.8

638

3816

R05

ICPC

Cough

1.3

26.8

1835

13444

L01

ICPC

Neck symptom/complaint

1.5

26.8

1084

7267

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

26.8

1065

7116

G04BD12

ATC

mirabegron; oral

1.4

26.5

1285

8899

H20.1

ICD-10 Finland

Chronic iridocyclitis

4.2

26.4

156

D82

ICPC

Teeth/gum disease

1.3

26.4

2085

15593

DAX08

NOMESCO Finland

Fitting of hearing aid

1.6

26.4

650

3920

D31.3

ICD-10 Finland

Benign neoplasm: Choroid

2.5

26.4

161

600

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.5

26.3

961

6313

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

26.2

2365

18013

L08

ICPC

Shoulder symptom/complaint

1.4

26.2

1713

12455

R60.0

ICD-10 Finland

Localized oedema

1.4

26.1

1289

8952

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

26.1

913

5947

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

25.9

1201

8250

N02AX02

ATC

tramadol; systemic, rectal

1.3

25.9

3803

30789

M25.5

ICD-10 Finland

Pain in joint

1.3

25.8

2088

15666

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

25.7

1047

7024

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

25.6

2476

19030

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

25.5

7047

61358

CKC15

NOMESCO Finland

Panretinal photocoagulation

5.1

25.4

100

H3601, E103,

ICD-10 Finland

+∞

25.4

M01AH05

ATC

etoricoxib; oral

1.3

25.2

4245

34876

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

25.1

2328

17780

N17

ICPC

Vertigo/dizziness

1.4

25.0

1239

8607

H16.0

ICD-10 Finland

Corneal ulcer

1.9

24.9

296

1448

207

Kela drug reimbursment

Chronic arrhythmias

1.3

24.9

2035

15275

G04CA02

ATC

tamsulosin; oral

1.3

24.9

2533

19584

H29

ICPC

Ear symptom/complaint other

1.4

24.8

1026

6903

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

24.7

1082

7353

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.5

24.6

825

5326

L13

ICPC

Hip symptom/complaint

1.3

24.5

1721

12636

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

24.4

919

6071

M03BX02

ATC

tizanidine; oral

1.2

24.3

4094

33593

R01AD09

ATC

mometasone; nasal

1.3

24.3

2884

22719

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

6.7

24.2

H35.4

ICD-10 Finland

Peripheral retinal degeneration

3.7

24.1

197

C01DA14

ATC

isosorbide mononitrate; oral

1.3

24.1

2272

17376

H40.19

ICD-10 Finland

Other primary glaucoma with open ventricular angle

122.5

24.0

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

23.9

1649

12069

CKD40

NOMESCO Finland

Endophotocoagulation of retina

3.0

23.9

109

349

N06AX21

ATC

duloxetine; oral

1.5

23.8

763

4878

SPAT1101

SPAT

Orthostatic test

1.6

23.7

580

3492

H57.1

ICD-10 Finland

Ocular pain

2.2

23.5

210

925

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

23.5

1889

14134

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

23.4

2415

18678

H01.0

ICD-10 Finland

Blepharitis

1.8

23.1

373

2011

M01AB05

ATC

diclofenac; systemic, rectal

1.2

23.0

5063

42675

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

23.0

3010

23950

H03AA01

ATC

levothyroxine sodium; systemic

1.3

22.9

2005

15166

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

22.9

1424

10253

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

22.9

2571

20079

S06.0

ICD-10 Finland

Concussion

1.5

22.9

881

5841

A10AE05

ATC

insulin detemir; parenteral

1.8

22.9

384

2094

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

22.8

1255

8864

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.8

22.8

362

1943

C09CA06

ATC

candesartan; oral

1.3

22.7

1886

14162

R05

ICD-10 Finland

Cough

1.3

22.7

1675

12372

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

22.7

2238

17195

SPAT1172

SPAT

Guidance concerning hydration

1.8

22.7

342

1807

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.5

22.7

795

5175

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

4.0

22.7

150

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

22.6

1167

8154

T89

ICPC

Diabetes insulin dependent

2.3

22.6

168

686

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.7

22.6

413

2307

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

22.5

939

6322

H3602, E113,

ICD-10 Finland

+∞

22.4

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

22.4

484

2827

R01AD12

ATC

fluticasone furoate; nasal

1.3

22.2

1576

11571

H35.3

ICD-10 Finland

Degeneration of macula and posterior pole

9.4

22.1

C08CA13

ATC

lercanidipine; oral

1.3

22.1

1499

10934

H33.0

ICD-10 Finland

Retinal detachment with retinal break

2.0

22.0

235

1109

F93

ICPC

Glaucoma

6.0

22.0

RK322, ,

NOMESCO Finland

8.8

21.8

H43.3

ICD-10 Finland

Other vitreous opacities

2.7

21.8

115

399

C09AA05

ATC

ramipril; oral

1.3

21.7

2780

22027

L57.0

ICD-10 Finland

Actinic keratosis

1.4

21.6

1296

9273

J01CA08

ATC

pivmecillinam; oral

1.2

21.6

3441

27942

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.4

21.5

936

6347

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

21.5

2887

23002

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

2.8

21.5

106

355

N04BC05

ATC

pramipexole; oral

1.5

21.4

738

4789

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

33.0

21.3

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

21.2

1532

11272

A01

ICPC

Pain general/multiple sites

1.5

21.1

819

5438

OAB50, ,

SPAT

1.7

21.0

416

2375

J01MA12

ATC

levofloxacin; systemic

1.3

21.0

1741

13056

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

21.0

653

4148

E000001, ,

ATC

1.3

20.9

1505

11067

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

20.8

777

5121

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

20.8

2130

16419

G04CB01

ATC

finasteride; oral

1.3

20.8

1314

9478

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

20.7

775

5107

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

20.7

689

4436

J01FF01

ATC

clindamycin; systemic

1.3

20.7

2027

15531

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

20.7

1476

10834

KMAK, ,

NOMESCO Finland

1.2

20.6

3204

25912

N05CF01

ATC

zopiclone; oral

1.2

20.6

3211

25977

S01.0

ICD-10 Finland

Open wound of scalp

1.5

20.6

751

4927

A10BH05

ATC

linagliptin; oral

1.5

20.5

572

3548

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

20.5

817

5451

J01FA10

ATC

azithromycin; systemic

1.2

20.5

3639

29852

N05BA04

ATC

oxazepam; oral

1.3

20.3

2225

17282

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

20.1

1103

7775

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.2

19.9

2807

22442

M01AC06

ATC

meloxicam; systemic, rectal

1.2

19.8

2881

23107

WX142

NOMESCO Finland

Sub-tenon anesthesy

3.7

19.8

157

L15

ICPC

Knee symptom/complaint

1.3

19.8

1867

14231

SPAT1167

SPAT

Insertion of urinary catheter

1.7

19.7

403

2320

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

19.7

1421

10445

JN4AD

NOMESCO Finland

Body CT examination

1.4

19.5

912

6258

WX002

NOMESCO Finland

Sedation and analgesia

1.3

19.4

1716

12966

S70.0

ICD-10 Finland

Contusion of hip

1.6

19.3

420

2458

SFA30

NOMESCO Finland

Three-surface restoration

1.2

19.3

2647

21087

CKC20

NOMESCO Finland

Cryopexy of undetached retina

6.9

19.2

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

19.1

921

6352

CKA10

NOMESCO Finland

Biopsy of vitreous body

6.6

19.1

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.6

19.1

456

2728

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.5

19.1

624

4002

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

19.1

3955

32880

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.4

19.1

961

6678

B01AC04

ATC

clopidogrel; oral

1.3

18.9

1840

14065

A10BA02

ATC

metformin; oral

1.2

18.9

2682

21436

M02AA07

ATC

piroxicam; topical

1.2

18.8

3391

27784

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

18.8

386

2224

Z71.8

ICD-10 Finland

Other specified counselling

1.3

18.6

2067

16056

ZXC50

NOMESCO Finland

Cryotherapy

1.7

18.6

364

2073

G44.2

ICD-10 Finland

Tension-type headache

1.4

18.6

844

5763

WX723

NOMESCO Finland

CPAP therapy

2.0

18.5

198

935

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

18.5

1011

7118

I95.1

ICD-10 Finland

Orthostatic hypotension

1.6

18.5

494

3034

M15

ICD-10 Finland

Polyarthrosis

1.5

18.5

518

3216

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.6

18.5

422

2499

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

18.4

1511

11294

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.3

18.4

1138

8172

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

18.3

917

6368

CKD60

NOMESCO Finland

Anterior vitrectomy

2.5

18.2

110

409

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

18.1

2754

22149

K85

ICPC

Elevated blood pressure

1.3

18.1

1618

12234

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.5

18.0

562

3570

H02.3

ICD-10 Finland

Blepharochalasis

1.5

18.0

603

3888

H53.4

ICD-10 Finland

Visual field defects

2.0

18.0

187

875

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

17.9

1523

11433

R52.9

ICD-10 Finland

Pain, unspecified

1.4

17.9

737

4943

B01AB05

ATC

enoxaparin; parenteral

1.2

17.9

2912

23584

N02BF02

ATC

pregabalin; oral

1.6

17.8

390

2286

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

4.7

17.8

R11

ICD-10 Finland

Nausea and vomiting

1.4

17.7

742

4994

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

17.7

905

6305

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

17.7

1266

9285

H44.0

ICD-10 Finland

Purulent endophthalmitis

6.1

17.6

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

17.6

839

5775

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

17.5

665

4392

RS226, ,

NOMESCO Finland

49.4

17.4

-44

ICPC

Preventive immunization/medic

1.4

17.4

825

5672

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.3

17.4

1440

10769

H61.2

ICD-10 Finland

Impacted cerumen

1.5

17.4

590

3813

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

17.4

1261

9262

A02BC03

ATC

lansoprazole; oral

1.2

17.4

2603

20886

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

17.3

1542

11643

R55

ICD-10 Finland

Syncope and collapse

1.3

17.3

1168

8494

R06AE07

ATC

cetirizine; oral

1.2

17.2

3044

24839

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

17.2

709

4756

Z02.7

ICD-10 Finland

Issue of medical certificate

1.5

17.2

579

3738

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.6

17.1

399

2375

H40.12

ICD-10 Finland

Pigmentary glaucoma

89.5

17.1

M01AX05

ATC

glucosamine; oral

1.2

17.1

2196

17324

SCA02

NOMESCO Finland

Preventive oral health care

1.5

17.1

540

3441

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.2

17.1

2761

22323

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

17.1

1088

7844

H54.3

ICD-10 Finland

Mild or no visual impairment, binocular

4.5

17.0

U02

ICPC

Urinary frequency/urgency

1.3

17.0

1224

8979

N02BF01

ATC

gabapentin; oral

1.5

17.0

568

3660

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

17.0

1264

9316

H18.5

ICD-10 Finland

Hereditary corneal dystrophies

2.7

16.9

325

SPAT1009

SPAT

Measurement of intraocular pressure

2.4

16.9

112

436

R4135

NOMESCO Finland

Rehabilitation for hearing problems

1.8

16.9

232

1194

R4110, ,

SPAT

1.4

16.8

661

4396

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

16.7

430

2619

EBA00

NOMESCO Finland

Extraction of tooth

1.2

16.7

2393

19096

S97

ICPC

Chronic ulcer skin

1.5

16.6

594

3878

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.7

16.6

305

1708

-1, ,

NOMESCO Finland

1.3

16.6

1906

14841

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

16.5

621

4097

G47.3

ICD-10 Finland

Sleep apnoea

1.3

16.4

1328

9897

J02AC01

ATC

fluconazole; systemic

1.2

16.4

2473

19835

H25.9

ICD-10 Finland

Senile cataract, unspecified

1.9

16.4

200

991

CKD15

NOMESCO Finland

Injection of vitreous substitute

4.0

16.3

108

3651B

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA CAPSULARE (AVOKULMA)]

+∞

16.3

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

16.3

955

6797

A11

ICPC

Chest pain NOS

1.4

16.2

734

5005

T85.2

ICD-10 Finland

Mechanical complication of intraocular lens

3.4

16.1

166

WZC30

NOMESCO Finland

Teaching

1.3

16.1

1151

8430

P01AB01

ATC

metronidazole; oral, rectal

1.2

16.1

2854

23258

H84

ICPC

Presbyacusis

1.5

16.1

484

3052

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

1.7

16.1

294

1645

SPAT1058

SPAT

PEF monitoring instruction

1.4

16.0

654

4380

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.4

16.0

767

5285

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

15.9

1616

12392

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

1.9

15.9

195

967

1LA01, ,

NOMESCO Finland

15.3

15.9

RS222, ,

NOMESCO Finland

2.3

15.7

116

474

A29

ICPC

General symptom/complaint other

1.3

15.7

1162

8553

S01

ICPC

Pain/tenderness of skin

1.6

15.7

365

2172

WX320

NOMESCO Finland

Spinalanesthesy

1.2

15.7

2110

16707

L14

ICPC

Leg/thigh symptom/complaint

1.4

15.6

678

4592

TQW80

NOMESCO Finland

Local dermatologic skincare

1.8

15.6

222

1156

H02.0

ICD-10 Finland

Entropion and trichiasis of eyelid

1.8

15.5

252

1365

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

15.4

1080

7886

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.1

15.4

195

D06BX01

ATC

metronidazole; topical

1.4

15.4

702

4794

M54

ICD-10 Finland

Dorsalgia

1.4

15.3

740

5102

CHD50

NOMESCO Finland

Shunt operation on anterior chamber

+∞

15.3

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

15.2

905

6451

Z3231

NOMESCO Finland

Registered nurse

1.2

15.1

2280

18258

3708

FHL

Trabeculectomy or equivalent

150.6

15.1

CFW99

NOMESCO Finland

Other operation on conjunctiva

24.7

15.1

K59.0

ICD-10 Finland

Constipation

1.5

15.0

566

3733

J01EA01

ATC

trimethoprim; systemic

1.2

15.0

2480

20044

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.4

14.9

794

5567

M05BA04

ATC

alendronic acid; oral

1.3

14.8

1069

7838

SPAT1231

SPAT

Assessment of adjustments needed in living environment

1.8

14.8

228

1216

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

14.8

808

5685

C02AC05

ATC

moxonidine; oral

1.5

14.8

432

2709

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.3

14.7

1060

7768

A46

ICD-10 Finland

Erysipelas

1.3

14.7

1371

10397

G04CB02

ATC

dutasteride; oral

1.4

14.7

764

5334

A10BH01

ATC

sitagliptin; oral

1.4

14.7

838

5938

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.5

14.5

463

2955

J05AB01

ATC

aciclovir; systemic

1.3

14.5

1611

12470

N05AH04

ATC

quetiapine; oral

1.3

14.4

1071

7883

XFE00

NOMESCO Finland

Epicardial ultrasonography

1.8

14.4

231

1248

K59.1

ICD-10 Finland

Functional diarrhoea

1.5

14.4

447

2840

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

14.4

776

5450

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

14.3

570

3799

L16

ICPC

Ankle symptom/complaint

1.4

14.3

753

5266

R81

ICPC

Pneumonia

1.6

14.2

298

1729

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.3

14.2

944

6840

M05BX04

ATC

denosumab; parenteral

1.4

14.2

651

4450

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.6

14.2

362

2203

D01BA02

ATC

terbinafine; oral

1.2

14.1

1920

15194

SPAT1360

SPAT

Extensive global examination

1.4

14.1

661

4533

RK321, ,

NOMESCO Finland

10.6

14.1

A10AC01

ATC

insulin (human); parenteral

1.4

14.1

561

3738

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

14.1

347

2094

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

14.1

1573

12183

I50.0

ICD-10 Finland

Congestive heart failure

1.3

14.0

1038

7634

G04CA01

ATC

alfuzosin; oral

1.3

14.0

1087

8046

S29

ICPC

Skin symptom/complaint other

1.3

14.0

1542

11925

R44.1

ICD-10 Finland

Visual hallucinations

2.8

14.0

243

R13

ICD-10 Finland

Dysphagia

1.4

13.9

593

4000

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

3.0

13.9

192

R4180

NOMESCO Finland

Podiatric therapy

2.4

13.9

348

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.2

13.8

154

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

13.7

4800

41377

A02BC01

ATC

omeprazole; systemic

1.2

13.7

2526

20599

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.2

13.7

2321

18776

D07AD01

ATC

clobetasol; topical

1.3

13.7

1179

8847

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

1.8

13.7

188

969

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.7

13.7

236

1301

N07CA01

ATC

betahistine; oral

1.4

13.7

691

4800

R5110, ,

SPAT

1.4

13.7

630

4310

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

13.7

1076

7981

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.4

13.7

644

4423

H53

ICD-10 Finland

Visual disturbances

3.1

13.6

165

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.5

13.6

481

3135

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

1.4

13.5

683

4743

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

1.9

13.4

166

827

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.4

13.4

763

5401

VALMI, ,

NOMESCO Finland

1.3

13.4

1345

10286

C09CA03

ATC

valsartan; oral

1.3

13.3

827

5931

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.4

13.3

592

4025

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.4

13.3

603

4113

J20

ICD-10 Finland

Acute bronchitis

1.4

13.3

694

4846

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

13.3

704

4930

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

13.3

1509

11706

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.3

13.2

906

6591

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.4

13.2

641

4423

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.9

13.2

151

734

F43

ICPC

Eye, Other diagnostic procedure

2.1

13.1

126

575

ZYC01, ,

SPAT

1.5

13.1

478

3136

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

1.7

13.1

239

1339

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

32.0

13.1

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.5

13.1

399

2526

WZC30, ,

SPAT

1.5

13.1

388

2442

WX290

NOMESCO Finland

Other blockage of nerve

1.2

13.1

2187

17659

N01

ICPC

Headache

1.4

13.1

504

3341

R3120

NOMESCO Finland

Training in mobility skills

3.8

13.0

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.4

13.0

541

3635

R06AX27

ATC

desloratadine; oral

1.3

13.0

1392

10723

R01AD58

ATC

fluticasone, combinations; nasal

1.3

12.9

1024

7597

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.4

12.9

539

3623

N06AX16

ATC

venlafaxine; oral

1.4

12.9

666

4641

M01AH02

ATC

rofecoxib; oral

1.3

12.9

1199

9083

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

12.8

1688

13298

H53.8

ICD-10 Finland

Other visual disturbances

2.3

12.8

390

L29

ICPC

Musculoskeletal sympt/complt other

1.4

12.8

660

4601

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.3

12.8

942

6924

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.7

12.8

254

1456

F84

ICPC

Macular degeneration

37.6

12.8

M01AE02

ATC

naproxen; oral, rectal

1.2

12.7

3968

33811

SDA03

NOMESCO Finland

Periodontal treatment

1.2

12.7

2197

17787

A06AD11

ATC

lactulose; oral

1.2

12.7

1728

13660

K78

ICPC

Atrial fibrillation/flutter

1.3

12.7

931

6838

CKD93

NOMESCO Finland

Extended combined procedure on vitreous body and retina

3.3

12.7

134

H91.9

ICD-10 Finland

Hearing loss, unspecified

1.5

12.7

429

2774

A10AB04

ATC

insulin lispro; parenteral

2.1

12.6

116

520

R03AK08

ATC

formoterol and beclometasone; inhalant

1.6

12.6

277

1627

SPAT1251

SPAT

Organisation of medication

1.5

12.6

365

2284

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

12.6

871

6342

C08CA02

ATC

felodipine; oral

1.3

12.6

1054

7875

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.3

12.6

754

5381

SPAT1285

SPAT

Provision of consultation response

1.5

12.6

436

2833

R12

ICD-10 Finland

Heartburn

1.4

12.5

511

3422

ZXE10

NOMESCO Finland

More than one and less than three hours

1.2

12.5

3006

25063

WW200, ,

SPAT

1.2

12.5

1535

12003

K07

ICPC

Swollen ankles/oedema

1.4

12.4

504

3372

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

1.7

12.4

244

1395

HAHOM, ,

NOMESCO Finland

2.6

12.4

248

L60.0

ICD-10 Finland

Ingrowing nail

1.6

12.4

316

1924

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.6

12.4

318

1939

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.4

12.4

530

3581

ZXD05

NOMESCO Finland

Urgent procedure

1.2

12.3

2435

19952

H02.4

ICD-10 Finland

Ptosis of eyelid

1.7

12.3

234

1326

N06AX26

ATC

vortioxetine; oral

1.5

12.3

324

1989

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.6

12.2

295

1774

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.2

12.2

1787

14227

TCG00

NOMESCO Finland

Protection of cornea and sclera with soft lens

4.7

12.2

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.5

12.2

383

2440

M01AH01

ATC

celecoxib; oral

1.2

12.2

1483

11584

S22.3

ICD-10 Finland

Fracture of rib

1.4

12.1

549

3744

Z00.8

ICD-10 Finland

Other general examinations

1.4

12.1

525

3553

M54.2

ICD-10 Finland

Cervicalgia

1.4

12.1

456

3011

R04.0

ICD-10 Finland

Epistaxis

1.3

12.1

742

5314

H33.1

ICD-10 Finland

Retinoschisis and retinal cysts

2.9

12.1

188

CHB10

NOMESCO Finland

Puncture of anterior chamber of eye with irrigation

3.2

12.0

139

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

11.9

550

3763

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

1.5

11.9

398

2566

R52.2

ICD-10 Finland

Other chronic pain

1.6

11.9

243

1402

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.3

11.9

887

6525

N02AA05

ATC

oxycodone; systemic

1.2

11.9

1895

15207

WZB00, ,

SPAT

1.5

11.9

368

2337

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

2.5

11.9

287

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.7

11.9

229

1303

U07

ICPC

Urine symptom/complaint other

1.4

11.9

650

4575

J45.9

ICD-10 Finland

Asthma, unspecified

1.2

11.8

1475

11545

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.4

11.8

468

3120

H04AA01

ATC

glucagon; nasal, parenteral

2.8

11.8

201

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.4

11.8

506

3422

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.5

11.7

373

2382

SPAT1014

SPAT

Treatment of eyes

1.8

11.7

177

941

1LA04, ,

NOMESCO Finland

9.8

11.7

N30.9

ICD-10 Finland

Cystitis, unspecified

1.4

11.7

579

4011

M79.1

ICD-10 Finland

Myalgia

1.3

11.6

866

6370

R33

ICD-10 Finland

Retention of urine

1.3

11.6

837

6129

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.7

11.6

210

1174

M02AA10

ATC

ketoprofen; topical

1.2

11.6

1315

10185

W19

ICD-10 Finland

Unspecified fall

1.3

11.6

851

6249

K30

ICD-10 Finland

Functional dyspepsia

1.3

11.6

745

5371

R74

ICPC

Upper respiratory infection acute

1.2

11.6

1328

10302

N06AB10

ATC

escitalopram; oral

1.3

11.5

1025

7714

RK320, ,

NOMESCO Finland

2.3

11.5

337

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

11.5

1163

8889

CH2X4

NOMESCO Finland

Optical coherence tomography (OCT) of iris and iridocorneal angle

9.4

11.4

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

2.0

11.4

114

528

SPAT1125

SPAT

Stoma care and guidance

1.7

11.4

202

1123

IHZ05, ,

SPAT

2.4

11.4

304

H26.2

ICD-10 Finland

Complicated cataract

2.4

11.4

304

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.2

11.4

1820

14609

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.4

11.3

429

2835

H40.3

ICD-10 Finland

Glaucoma secondary to eye trauma

61.1

11.3

CHF15

NOMESCO Finland

Cryotherapy of ciliary body

61.1

11.3

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.3

11.3

1114

8493

R01AD08

ATC

fluticasone; nasal

1.2

11.3

1703

13592

R07.3

ICD-10 Finland

Other chest pain

1.3

11.3

801

5857

A10AA01, ,

ATC

2.3

11.2

341

CK2Z4

NOMESCO Finland

Ocular fundus light imaging (OCT), angiography

15.4

11.2

U01

ICPC

Dysuria/painful urination

1.4

11.2

587

4101

I49.5

ICD-10 Finland

Sick sinus syndrome

1.4

11.2

479

3236

E03

ICD-10 Finland

Other hypothyroidism

1.4

11.2

433

2874

AXX01, ,

SPAT

1.5

11.2

302

1865

EB1VA, ,

NOMESCO Finland

1.4

11.1

605

4252

E000006, ,

ATC

1.4

11.1

516

3535

U05

ICPC

Urination problems other

1.4

11.1

482

3264

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

11.1

492

3344

J05AB11

ATC

valaciclovir; oral

1.3

11.1

985

7412

D11

ICPC

Diarrhoea

1.4

11.1

631

4467

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

2.0

11.1

118

560

SGA01

NOMESCO Finland

Emergency treatment

1.4

11.1

609

4288

S82

ICPC

Naevus/mole

1.3

11.1

909

6774

OAB42, ,

SPAT

1.4

11.1

564

3925

SPAT1059

SPAT

Spirometry at the office

1.5

11.0

390

2544

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.4

11.0

499

3405

H53.2

ICD-10 Finland

Diplopia

1.6

11.0

243

1432

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

11.0

1161

8919

J01FA06

ATC

roxithromycin; oral

1.2

11.0

3110

26212

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.4

10.9

456

3067

F99

ICPC

Eye/adnexa disease other

2.7

10.9

210

R03DC03

ATC

montelukast; oral

1.3

10.8

962

7238

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

1.6

10.8

251

1496

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

10.8

1969

15990

H82

ICPC

Vertiginous syndrome

1.8

10.8

160

847

XX3DW

NOMESCO Finland

Time consuming IT work

1.3

10.8

817

6025

N30

ICD-10 Finland

Cystitis

1.4

10.8

566

3958

L86

ICPC

Back syndrome with radiating pain

1.4

10.7

425

2833

K25

ICPC

Fear of hypertension

1.5

10.7

348

2233

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.3

10.7

781

5730

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

10.7

1664

13311

R01AD01

ATC

beclometasone; nasal

1.3

10.6

955

7198

A10AE06

ATC

insulin degludec; parenteral

1.8

10.6

150

783

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

1.5

10.6

278

1706

N19

ICD-10 Finland

Unspecified kidney failure

1.4

10.6

386

2534

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

1.7

10.6

207

1184

AN1

Coronary angiography

1.2

10.6

1205

9336

Z71.9

ICD-10 Finland

Counselling, unspecified

1.4

10.5

457

3096

SFA00

NOMESCO Finland

Small restoration

1.3

10.5

781

5742

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

10.5

573

4029

ZXD20

NOMESCO Finland

Day surgery

1.3

10.4

884

6612

R31

ICD-10 Finland

Unspecified haematuria

1.3

10.4

989

7503

B01AF01

ATC

rivaroxaban; oral

1.2

10.4

1206

9360

CA1AE

NOMESCO Finland

Eye and orbita ultrasound examination

3.2

10.4

122

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

10.4

1905

15470

R95

ICPC

Chron obstructive pulmonary disease

1.6

10.4

260

1579

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.4

10.4

486

3336

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

2.9

10.4

157

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

1.7

10.4

194

1097

XX2RW, ,

NOMESCO Finland

2.4

10.3

283

F01

ICPC

Eye pain

1.8

10.3

159

851

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

56.5

10.3

A10AD05

ATC

insulin aspart; parenteral

1.7

10.3

172

942

S01AX11

ATC

[U] ofloxacin

1.5

10.3

312

1974

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

1.6

10.3

248

1492

A08

ICPC

Swelling

1.4

10.3

486

3340

H35.1

ICD-10 Finland

Retinopathy of prematurity

9.9

10.3

A03

ICPC

Fever

1.3

10.3

796

5885

C10AA07

ATC

rosuvastatin; oral

1.2

10.3

2398

19876

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.3

10.3

875

6549

S01BA01

ATC

dexamethasone; ophthalmic

1.6

10.3

241

1442

A02BC04

ATC

rabeprazole; oral

1.4

10.2

526

3665

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.3

10.2

709

5165

Z00.0

ICD-10 Finland

General medical examination

1.2

10.2

1489

11833

CHD10

NOMESCO Finland

Trabeculectomy

+∞

10.2

37520

ICD-8 Finland

Glaucoma, Secondary

+∞

10.2

A10AA02, ,

ATC

1.7

10.2

170

932

H36.02

ICD-10 Finland

Preproliferative diabetic retinopathy

103.5

10.1

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

1.7

10.1

177

982

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

1.7

10.1

163

884

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.3

10.1

646

4652

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.5

10.0

299

1886

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.3

10.0

568

4018

ZXH06, ,

SPAT

1.5

10.0

281

1751

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.5

9.9

264

1625

B02.9

ICD-10 Finland

Zoster without complication

1.3

9.9

558

3944

R03BA08

ATC

ciclesonide; inhalant

1.4

9.9

512

3571

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.3

9.9

705

5155

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

9.9

1182

9201

Z2446

NOMESCO Finland

Social worker

1.4

9.8

419

2831

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.6

9.8

228

1361

H27.1

ICD-10 Finland

Dislocation of lens

2.8

9.8

162

XF640, ,

NOMESCO Finland

1.5

9.8

261

1608

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.5

9.7

297

1883

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

9.7

1548

12399

N03AE01

ATC

clonazepam; systemic

1.4

9.7

393

2630

TPH04

NOMESCO Finland

Cathetrisation of vein

1.2

9.7

1781

14451

C03AA03

ATC

hydrochlorothiazide; oral

1.3

9.7

979

7480

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.2

9.7

1583

12714

R1250, ,

SPAT

1.8

9.7

133

689

H33.5

ICD-10 Finland

Other retinal detachments

2.5

9.6

212

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

9.6

1284

10110

CKD99

NOMESCO Finland

Other intraoclular operations on vitreous body and retina

13.7

9.6

J01MA06

ATC

norfloxacin; oral

1.2

9.6

1124

8728

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.0

9.6

434

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.3

9.6

549

3893

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.6

9.6

198

1150

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.2

9.5

1512

12105

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.4

9.5

404

2728

3650A

ICD-9 Finland

Glaucoma, Borderline glaucoma [glaucoma suspect][SUSPICIO GLAUCOMATIS (AVOKULMA)]

3.5

9.5

R03BB04

ATC

tiotropium bromide; inhalant

1.3

9.5

992

7608

L90

ICPC

Osteoarthrosis of knee

1.3

9.5

575

4111

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

1.5

9.5

269

1681

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.4

9.5

471

3267

S22

ICPC

Nail symptom/complaint

1.4

9.5

471

3267

B81

ICPC

Anaemia vit B12/folate deficiency

1.4

9.5

376

2510

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.4

9.4

423

2883

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

5.3

9.4

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.7

9.3

334

4433

SPAT1104

SPAT

Monitoring of emergency patient

1.3

9.3

548

3901

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

9.3

1347

10692

H44.5

ICD-10 Finland

Degenerated conditions of globe

12.5

9.3

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.3

9.3

585

4207

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.6

9.3

185

1065

K86

ICPC

Hypertension uncomplicated

1.2

9.3

1217

9565

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

1.8

9.3

137

726

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.6

9.3

213

1270

S01AD03

ATC

aciclovir; ophthalmic

1.5

9.2

250

1546

H20.8

ICD-10 Finland

Other iridocyclitis

3.8

9.2

SPAT1281

SPAT

Other administrative function

1.3

9.2

568

4072

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.4

9.2

352

2334

K29

ICPC

Cardiovascular sympt/complt other

1.4

9.2

407

2769

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.3

9.2

859

6503

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.4

9.2

493

3461

SPF30

NOMESCO Finland

Relining of denture

1.6

9.2

182

1046

H44.1

ICD-10 Finland

Other endophthalmitis

4.7

9.2

CHC03

NOMESCO Finland

Laser iridoplasty

94.1

9.2

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.2

9.2

1256

9914

K07.60

ICD-10 Finland

Snapping jaw

1.6

9.1

181

1040

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.3

9.1

662

4855

XJH00

NOMESCO Finland

Transanal ultrasonography

1.3

9.0

605

4387

S19

ICPC

Skin injury other

1.5

9.0

302

1953

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

9.0

779

5842

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.4

9.0

462

3222

H02BX01

ATC

methylprednisolone, combinations; systemic

1.3

8.9

511

3623

XKC03

NOMESCO Finland

Water cystometry

1.5

8.9

247

1536

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

1.5

8.9

257

1613

S21

ICPC

Skin texture symptom/complaint

1.2

8.9

1113

8704

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

1.6

8.9

218

1320

C09AA02

ATC

enalapril; systemic

1.2

8.9

2030

16772

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.2

8.9

1018

7888

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.6

8.8

223

1359

L04AX03

ATC

methotrexate; systemic

1.3

8.8

582

4212

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.5

8.8

254

1593

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.3

8.8

648

4761

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

8.8

1919

15793

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.3

8.8

712

5296

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.4

8.8

421

2903

78930

ICD-8 Finland

Abnormal urinary constituents of unspecified cause, Haematuria

2.3

8.8

251

K03.66

ICD-10 Finland

Tooth plaque

1.4

8.8

451

3145

SBB10

NOMESCO Finland

Dental impressions

1.5

8.8

259

1633

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

3.8

8.8

J01MA14

ATC

moxifloxacin; systemic

1.3

8.8

665

4905

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.4

8.8

388

2641

R03BA05

ATC

fluticasone; inhalant

1.2

8.7

1238

9801

X58

ICD-10 Finland

Exposure to other specified factors

1.3

8.7

778

5855

M10.9

ICD-10 Finland

Gout, unspecified

1.3

8.7

624

4566

J01DA01

ATC

[U] cefalexin

1.1

8.7

4983

43890

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

1.5

8.7

262

1658

H81.3

ICD-10 Finland

Other peripheral vertigo

1.6

8.7

221

1349

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.4

8.7

375

2541

S06

ICPC

Rash localized

1.4

8.7

438

3046

SPAT1252

SPAT

Overall medication plan or its review

1.3

8.7

670

4954

130

Kela drug reimbursment

Malignant tumour

0.8

8.7

497

6120

A10AB01

ATC

insulin (human); parenteral

1.7

8.7

140

762

M54.3

ICD-10 Finland

Sciatica

1.4

8.7

388

2646

N18.8

ICD-10 Finland

Other chronic renal failure

1.5

8.6

232

1434

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

1.7

8.6

169

969

XF404

NOMESCO Finland

Ambulatory ECG

1.3

8.6

768

5780

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

1.7

8.6

164

934

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.4

8.6

447

3124

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.2

8.6

1099

8613

R21

ICPC

Throat symptom/complaint

1.3

8.6

851

6487

H54.4

ICD-10 Finland

Blindness, monocular

3.6

8.6

RK110, ,

NOMESCO Finland

2.2

8.6

308

WX780

NOMESCO Finland

Remote monitoring CPAP

1.6

8.5

181

1059

ZYD01, ,

SPAT

2.6

8.5

175

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.3

8.5

715

5344

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

8.5

1924

15878

XQ848

NOMESCO Finland

Dermatological photography

1.5

8.5

223

1372

L76

ICPC

Fracture: other

1.5

8.5

272

1745

M75

ICD-10 Finland

Shoulder lesions

1.5

8.5

269

1722

R50.9

ICD-10 Finland

Fever, unspecified

1.2

8.5

1101

8641

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.3

8.5

503

3587

C07AB02

ATC

metoprolol; systemic

1.2

8.5

2293

19188

J45

ICD-10 Finland

Asthma

1.3

8.5

640

4720

F06.7

ICD-10 Finland

Mild cognitive disorder

1.4

8.4

332

2216

E000003, ,

ATC

1.5

8.4

266

1703

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

2.1

8.4

317

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

1.5

8.4

247

1558

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

8.4

233

1452

S01.50

ICD-10 Finland

Open wound in oral cavity

2.2

8.4

305

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.4

8.3

360

2440

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

1.8

8.3

125

666

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.4

8.3

439

3074

A07EA06

ATC

budesonide; oral, local oral

1.6

8.3

203

1228

SPAT1291

SPAT

Other function in accordance with NCSP classification

1.8

8.3

110

564

R51

ICD-10 Finland

Headache

1.5

8.3

253

1606

C07AG02

ATC

carvedilol; oral

1.3

8.3

577

4208

S01BA07

ATC

fluorometholone; ophthalmic

2.0

8.3

426

B35.1

ICD-10 Finland

Tinea unguium

1.4

8.3

391

2691

C09DA06

ATC

candesartan and diuretics; oral

1.3

8.3

574

4185

S16

ICPC

Bruise/contusion

1.5

8.3

274

1770

SPAT1081

SPAT

Cardiorespiratory global assessment

1.3

8.3

528

3806

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.6

8.2

204

1239

H52.2

ICD-10 Finland

Astigmatism

2.0

8.2

376

SPAT1240

SPAT

Therapeutic discussion

1.4

8.2

408

2832

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.3

8.2

451

3180

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

1.8

8.2

122

649

H60

ICD-10 Finland

Otitis externa

1.5

8.2

236

1482

H53.3

ICD-10 Finland

Other disorders of binocular vision

3.4

8.2

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.3

8.2

704

5279

3652B

ICD-9 Finland

Glaucoma, Primary angle-closure glaucoma[KROONINEN AHDASKULMAGLAUKOOMA]

+∞

8.1

H40.29

ICD-10 Finland

Other [primary] glaucoma with closed ventricular angle

+∞

8.1

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.4

8.1

304

2009

J01FA09

ATC

clarithromycin; systemic

1.2

8.1

1884

15573

H92.0

ICD-10 Finland

Otalgia

1.4

8.1

292

1919

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.6

8.1

194

1171

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

1.8

8.0

121

646

N06AA09

ATC

amitriptyline; systemic

1.3

8.0

776

5898

E000002, ,

ATC

1.3

8.0

641

4761

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.5

8.0

210

1292

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.4

8.0

292

1922

G03CA04

ATC

estriol; systemic, vaginal

1.2

8.0

883

6814

H43.2

ICD-10 Finland

Crystalline deposits in vitreous body

3.2

8.0

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

1.6

8.0

199

1212

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.5

7.9

253

1622

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.6

7.9

173

1020

J01DA09

ATC

[U] cefadroxil

1.2

7.9

1759

14484

WX402

NOMESCO Finland

General anaesthesia

1.2

7.9

1189

9463

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.2

7.9

1332

10713

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.5

7.9

C03DA01

ATC

spironolactone; oral

1.2

7.9

1227

9796

D07XC01

ATC

betamethasone; topical

1.2

7.9

863

6650

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

1.5

7.9

227

1425

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

1.6

7.9

157

905

H52.1

ICD-10 Finland

Myopia

1.9

7.9

447

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

1.6

7.9

191

1155

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.2

7.9

968

7554

P06

ICPC

Sleep disturbance

1.3

7.9

589

4339

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

2.3

7.9

246

S01BA04

ATC

prednisolone; ophthalmic

1.6

7.9

167

979

L02

ICPC

Back symptom/complaint

1.3

7.9

558

4082

S76

ICPC

Skin infection other

1.4

7.8

376

2595

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.4

7.8

422

2968

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.3

7.8

694

5223

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.3

7.8

438

3100

R60.9

ICD-10 Finland

Oedema, unspecified

1.3

7.8

468

3346

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.4

7.8

305

2035

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.4

7.7

420

2956

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.6

7.7

187

1130

N05CF02

ATC

zolpidem; oral

1.2

7.7

1082

8555

D01

ICPC

Abdominal pain/cramps general

1.3

7.7

690

5197

SPAT1050

SPAT

Extensive neurological examination

1.6

7.7

174

1035

DFF15

NOMESCO Finland

Speech audiometry

1.3

7.7

447

3178

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.4

7.7

326

2204

K02

ICD-10 Finland

Dental caries

1.4

7.7

358

2459

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.4

7.7

336

2284

D02

ICPC

Abdominal pain epigastric

1.4

7.7

373

2580

R96

ICPC

Asthma

1.3

7.7

670

5031

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.5

7.7

270

1765

R06AE09

ATC

levocetirizine; oral

1.3

7.7

689

5192

A01AB09

ATC

miconazole; local oral

1.3

7.6

747

5685

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

2.3

7.6

243

G45.3

ICD-10 Finland

Amaurosis fugax

1.6

7.6

170

1008

R05FA02

ATC

opium derivatives and expectorants; systemic

1.1

7.6

3126

26883

A10BK03

ATC

empagliflozin; oral

1.3

7.5

642

4807

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.4

7.5

311

2094

CJ2M4

NOMESCO Finland

Scans and measurement printouts for intraocular lens power calculation

1.9

7.5

455

TCA15

NOMESCO Finland

Retrobulbar therapeutic injection into orbit

42.3

7.5

R06AX22

ATC

ebastine; oral

1.2

7.5

893

6947

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.5

7.5

207

1290

PE1AT

NOMESCO Finland

Femoral artery PTA

1.8

7.5

115

619

J01CF05

ATC

flucloxacillin; systemic

1.4

7.4

357

2465

PD5AD

NOMESCO Finland

CT of aorta

1.6

7.4

175

1052

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

7.4

1247

10028

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

1.5

7.4

249

1615

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.5

7.4

236

1515

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

1.9

7.4

464

AA5PD

NOMESCO Finland

CT examination of brain pefusion

2.0

7.4

340

M75.8

ICD-10 Finland

Other shoulder lesions

1.5

7.4

194

1196

K08.2

ICD-10 Finland

Atrophy of edentulous alveolar ridge

1.8

7.4

108

573

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

1.6

7.4

164

973

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

1.6

7.4

174

1047

OAB44, ,

SPAT

1.4

7.4

369

2567

U04

ICPC

Incontinence urine

1.3

7.3

545

4011

PD4AD

NOMESCO Finland

CT of lower extremity arteries

2.1

7.3

309

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.3

7.3

418

2966

K08.3

ICD-10 Finland

Retained dental root

1.3

7.3

539

3963

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

1.6

7.3

182

1109

-1, ,

SPAT

1.5

7.3

188

1154

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.3

7.3

440

3148

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

1.6

7.3

169

1013

CKD20

NOMESCO Finland

Removal of vitreous body substitute

2.8

7.3

123

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

1.7

7.3

117

638

B01AF03

ATC

edoxaban; oral

1.5

7.3

221

1405

SPAT1255

SPAT

Intravenous administration of medicine

1.3

7.3

530

3892

L75

ICPC

Fracture: femur

1.6

7.2

148

860

A02BA02

ATC

ranitidine; systemic

1.2

7.2

1797

14920

Z46.2

ICD-10 Finland

Fitting and adjustment of other devices related to nervous system and special senses

9.4

7.2

CA1AD

NOMESCO Finland

Orbita CT

4.0

7.2

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.5

7.2

206

1294

H54.0

ICD-10 Finland

Blindness, binocular

4.3

7.2

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.5

7.2

194

1204

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

7.2

591

4409

D07CC01

ATC

betamethasone and antibiotics; topical

1.2

7.2

818

6335

M05BA07

ATC

risedronic acid; oral

1.4

7.1

352

2442

SPAT1377

SPAT

Polysomnography

1.6

7.1

160

951

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

7.1

243

1580

KED22

NOMESCO Finland

Transurethral resection of prostate

1.3

7.1

585

4361

TCG20

NOMESCO Finland

Laser suture lysis in cornea or sclera

+∞

7.1

TPH07

NOMESCO Finland

Cathetrisation of artery

1.2

7.1

935

7345

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.4

7.1

254

1667

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.3

7.1

692

5266

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.3

7.1

477

3465

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.2

7.1

860

6701

H21.0

ICD-10 Finland

Hyphaema

3.1

7.1

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

1.4

7.1

326

2237

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

1.7

7.1

127

714

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.4

7.1

368

2576

SPAT1139

SPAT

Nutrition survey

1.4

7.0

278

1858

S72.0

ICD-10 Finland

Fracture of neck of femur

1.3

7.0

498

3643

D12

ICPC

Constipation

1.4

7.0

319

2184

ZZA00

NOMESCO Finland

Split skin graft

1.5

7.0

235

1523

C09DA03

ATC

valsartan and diuretics; oral

1.3

7.0

380

2676

CEC00

NOMESCO Finland

Recession of extraocular muscle

3.9

7.0

Z25.1

ICD-10 Finland

Need for immunization against influenza

1.4

7.0

358

2499

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.3

7.0

378

2661

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.3

7.0

428

3069

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.4

7.0

302

2051

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.4

7.0

333

2299

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

7.0

317

2171

H31.3

ICD-10 Finland

Choroidal haemorrhage and rupture

7.8

7.0

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

7.0

1370

11162

205

Kela drug reimbursment

Chronic hypertension

1.1

7.0

3137

27103

RK260, ,

NOMESCO Finland

8.8

7.0

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.3

7.0

435

3129

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.3

6.9

372

2616

H01

ICPC

Ear pain/earache

1.3

6.9

585

4379

ZXC15

NOMESCO Finland

Use of photodynamic technique

1.6

6.9

147

864

L95

ICPC

Osteoporosis

1.4

6.9

352

2457

S80.0

ICD-10 Finland

Contusion of knee

1.3

6.9

396

2814

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.3

6.9

373

2628

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.2

6.8

785

6083

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

1.4

6.8

261

1735

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

1.6

6.8

157

940

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.3

6.8

500

3677

B03BA03

ATC

hydroxocobalamin; parenteral

1.3

6.8

580

4346

J01AA07

ATC

tetracycline; systemic

1.2

6.8

719

5523

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.4

6.8

330

2286

EBA10

NOMESCO Finland

Operative extraction of tooth

1.3

6.8

455

3306

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.3

6.8

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

1.6

6.8

149

883

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.2

6.8

815

6348

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.2

6.8

722

5552

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.2

6.7

682

5212

P01BA02

ATC

hydroxychloroquine; oral

1.3

6.7

544

4048

R2130, ,

SPAT

2.0

6.7

307

A06AC51

ATC

ispaghula, combinations; oral

1.3

6.7

367

2588

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

6.7

1892

15843

CK2K4

NOMESCO Finland

Red-free imaging of ocular fundus

8.2

6.7

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

1.7

6.7

125

710

B80

ICPC

Iron deficiency anaemia

1.6

6.7

163

988

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

1.6

6.7

130

746

D07AB08

ATC

desonide; topical

1.2

6.7

738

5692

F05.9

ICD-10 Finland

Delirium, unspecified

1.5

6.7

211

1352

I78.1

ICD-10 Finland

Naevus, non-neoplastic

1.6

6.7

159

959

A97

ICPC

No disease

1.2

6.7

1338

10915

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.4

6.7

252

1671

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.4

6.7

245

1617

K99

ICPC

Cardiovascular disease other

1.4

6.7

256

1704

F83

ICPC

Retinopathy

12.9

6.6

K77

ICPC

Heart failure

1.4

6.6

262

1753

I50

ICD-10 Finland

Heart failure

1.3

6.6

384

2733

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.5

6.6

188

1180

ZX120, ,

SPAT

1.9

6.6

361

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.3

6.6

437

3169

C07AA05

ATC

propranolol; systemic

1.2

6.6

1131

9109

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.1

6.6

2050

17286

C09DA01

ATC

losartan and diuretics; oral

1.2

6.6

899

7090

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.3

6.6

463

3387

S01EX

ATC

Other antiglaucoma preparations

37.6

6.6

M04AA01

ATC

allopurinol; systemic

1.2

6.6

1342

10969

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.3

6.6

525

3904

H02AB02

ATC

dexamethasone; systemic

0.8

6.6

541

6352

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.3

6.5

455

3322

N81.6

ICD-10 Finland

Rectocele

1.3

6.5

486

3580

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.4

6.5

285

1940

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

1.5

6.5

163

995

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.4

6.5

248

1648

F94

ICPC

Blindness

7.8

6.5

SPAT1138

SPAT

Guidance concerning bowel function

1.6

6.5

135

789

SXC05

NOMESCO Finland

Other oral or dental procedure

1.4

6.5

278

1887

K05

ICPC

Irregular heartbeat other

1.4

6.5

268

1808

H34.1

ICD-10 Finland

Central retinal artery occlusion

2.1

6.5

261

F16

ICPC

Eyelid symptom/complaint

1.4

6.5

315

2184

H18.4

ICD-10 Finland

Corneal degeneration

2.5

6.5

148

H33.3

ICD-10 Finland

Retinal breaks without detachment

1.5

6.5

205

1317

HMAK, ,

NOMESCO Finland

1.3

6.4

590

4459

K07.4

ICD-10 Finland

Malocclusion, unspecified

2.1

6.4

274

G04BD08

ATC

solifenacin; oral

1.2

6.4

637

4857

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

1.6

6.4

141

835

M01AX17

ATC

nimesulide; oral

1.1

6.4

2066

17453

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

1.4

6.4

274

1859

R05FB02

ATC

cough suppressants and expectorants; systemic

1.1

6.4

3211

27891

SPAT1210

SPAT

Application of cast or individual aid

1.4

6.4

265

1789

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.3

6.4

592

4481

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

1.5

6.4

190

1206

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.3

6.4

410

2964

Z26.9

ICD-10 Finland

Need for immunization against unspecified infectious disease

1.8

6.4

481

L04AA06

ATC

mycophenolic acid; systemic

1.9

6.3

393

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

1.6

6.3

137

809

WYA10

NOMESCO Finland

Emergency care or similar visit

1.3

6.3

386

2768

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

1.5

6.3

193

1230

B01AB10

ATC

tinzaparin; parenteral

1.2

6.3

690

5319

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

1.8

6.3

475

B01AA03

ATC

warfarin; systemic

1.1

6.3

2370

20224

SPAT1147

SPAT

Destruction of skin lesion with external methods

1.6

6.3

127

737

WX725

NOMESCO Finland

Noninvasive ventilation

1.4

6.3

319

2225

G03DC05

ATC

[U] tibolone

1.3

6.3

391

2811

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.3

6.3

517

3858

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.4

6.3

225

1480

M50.3

ICD-10 Finland

Other cervical disc degeneration

1.6

6.3

130

760

S04

ICPC

Lump/swelling localized

1.2

6.3

649

4974

SPF02

NOMESCO Finland

Impression for dental prosthesis repair, restricted

1.7

6.3

110

616

R15

ICD-10 Finland

Faecal incontinence

1.4

6.3

246

1645

E87.5

ICD-10 Finland

Hyperkalaemia

1.5

6.3

165

1020

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.4

6.3

258

1740

A07AA02

ATC

nystatin; oral

1.3

6.2

511

3811

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.4

6.2

277

1892

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.3

6.2

352

2497

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.3

6.2

560

4224

N29

ICPC

Neurological sympt/complt other

1.6

6.2

142

850

XCC00

NOMESCO Finland

Investigative irrigation of lacrimal passages

1.8

6.2

512

SPAT1016

SPAT

Examination of vision

1.4

6.2

324

2272

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

1.7

6.2

106

590

L72.1

ICD-10 Finland

Trichilemmal cyst

1.3

6.2

399

2885

M54.6

ICD-10 Finland

Pain in thoracic spine

1.3

6.2

358

2550

SFC92

NOMESCO Finland

Other complicated additional procedure necessary for restorative treatment

1.3

6.2

382

2747

8010/3-C34.9

ICD-O-3

Carcinoma, NOS, of lung, NOS

0.0

6.2

146

D05AX52

ATC

calcipotriol, combinations; topical

1.4

6.2

295

2041

S61.8

ICD-10 Finland

Open wound of other parts of wrist and hand

1.6

6.1

121

699

H18.2

ICD-10 Finland

Other corneal oedema

3.2

6.1

IAA01, ,

SPAT

4.0

6.1

C05AA08

ATC

fluocortolone; rectal, topical

1.2

6.1

984

7879

K04.0

ICD-10 Finland

Pulpitis

1.4

6.1

273

1867

K02.2

ICD-10 Finland

Caries of cementum

1.4

6.1

321

2253

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.2

6.1

PAW37

NOMESCO Finland

Biopsy of temporal artery

1.8

6.1

405

H3601, E119,

ICD-10 Finland

+∞

6.1

WVA20, ,

SPAT

1.5

6.1

151

921

L12

ICPC

Hand/finger symptom/complaint

1.2

6.1

994

7969

C10AA04

ATC

fluvastatin; oral

1.2

6.1

919

7317

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.4

6.1

265

1805

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.4

6.1

227

1505

H60.8

ICD-10 Finland

Other otitis externa

1.5

6.1

151

922

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

1.7

6.1

104

579

H50.52

ICD-10 Finland

Exophoria

2.2

6.1

206

H93.1

ICD-10 Finland

Tinnitus

1.3

6.0

400

2903

WX720

NOMESCO Finland

Own respiration

1.4

6.0

276

1895

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.3

6.0

432

3168

H70

ICPC

Otitis externa

1.7

6.0

109

616

LEG10

NOMESCO Finland

Vaginal urethrocystopexy

1.5

6.0

168

1052

XF402

NOMESCO Finland

ECG with work load test

1.2

6.0

888

7056

A10BB12

ATC

glimepiride; oral

1.2

6.0

700

5435

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023103) Potassium [Moles/volume] in Serum or Plasma

8892

71537

2.81

198.71

25.8

22.4

4.01

4.00

mmol/l

6.44

8607

69316

(3019550) Sodium [Moles/volume] in Serum or Plasma

8885

71462

2.80

198.46

25.6

22.2

139.34

139.52

mmol/l

6.77

8615

69356

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8556

67747

2.47

194.70

21.3

18.5

25.72

27.75

mg/l

6.63

7367

56279

(3009542) Hematocrit [Volume Fraction] of Blood

8929

72172

2.83

193.85

31.4

27.2

38.14

38.72

10.54

8090

65662

(3035941) MCH [Entitic mass]

8929

72187

2.83

193.47

31.4

27.1

30.40

30.39

0.22

8725

70515

(3010813) Leukocytes [#/volume] in Blood

8930

72200

2.83

193.44

31.5

27.2

7.05

6.99

e9/l

0.92

8615

69270

(3000963) Hemoglobin [Mass/volume] in Blood

8930

72202

2.83

193.39

31.8

27.4

128.88

130.50

g/l

19.64

8731

70537

(3024731) MCV [Entitic volume]

8929

72190

2.82

193.39

31.4

27.1

92.04

91.88

2.53

8725

70524

(3026361) Erythrocytes [#/volume] in Blood

8929

72192

2.82

193.34

31.6

27.2

4.27

4.33

e12/l

21.34

8620

69247

(3007461) Platelets [#/volume] in Blood

8927

72184

2.82

192.91

31.6

27.2

239.04

240.41

e9/l

1.09

8642

69567

(3020564) Creatinine [Moles/volume] in Serum or Plasma

8747

70352

2.57

184.79

24.9

22.0

88.04

83.75

umol/l

15.90

8742

70315

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8732

70211

2.55

183.91

12.5

11.4

22.93

23.52

u/l

1.03

8232

66651

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

8275

65550

2.20

171.02

5.6

5.3

6.17

6.09

mmol/l

5.96

7021

57477

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

8048

63087

2.11

170.83

7.3

6.6

41.64

40.91

mmol/mol

8.76

7035

56389

(40761511) CBC panel - Blood by Automated count

8490

67963

2.30

170.67

21.8

17.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7939

62173

2.05

164.86

5.6

5.0

2.11

2.10

mu/l

0.09

6873

55015

(3013707) Erythrocyte sedimentation rate by Westergren method

6983

52472

1.87

162.89

4.9

4.3

16.01

15.59

mm/h

1.24

6189

47457

(3013826) Glucose [Moles/volume] in Serum or Plasma

6273

45883

1.79

156.49

4.9

4.6

6.98

6.84

mmol/l

4.43

5954

43111

(3037467) Urinalysis macro (dipstick) panel - Urine

6865

51609

1.84

155.94

5.7

5.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7397

56923

1.90

155.94

7.8

7.4

81.87

81.84

u/l

0.02

6843

52899

(3031040) Bacteria [#/volume] in Urine by Automated count

6879

51888

1.83

152.70

6.2

5.5

3462.46

1613.25

e6/l

1.12

915

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4800

32738

1.74

150.61

5.1

4.3

82.96

82.68

ng/l

0.00

3965

25883

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8191

65537

2.06

149.82

5.7

5.5

2.43

2.53

mmol/l

17.38

7093

58041

(3022217) INR in Platelet poor plasma by Coagulation assay

5749

41501

1.73

144.55

21.2

20.6

1.42

1.41

inr

0.07

1857

10955

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7944

63280

1.95

140.91

5.0

4.8

4.34

4.43

mmol/l

11.08

6897

56227

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7866

62506

1.93

139.78

5.1

4.7

1.48

1.47

mmol/l

0.82

6756

55059

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5811

42573

1.69

133.21

6.8

6.3

1.21

1.22

mmol/l

1.48

4631

35776

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6679

51042

1.72

128.39

4.5

4.1

15.40

15.22

pmol/l

5.97

5677

44839

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7613

60415

1.83

128.03

4.5

4.2

1.23

1.25

mmol/l

2.36

6457

52522

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2967

18386

1.74

124.87

1.8

1.7

14228285.18

26377988.49

pmol/l

0.85

2221

14573

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7770

62428

1.82

120.14

20.2

17.9

66.56

69.13

ml/min/173m2

24.60

6624

51577

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4288

29579

1.64

118.82

3.5

3.2

2015.61

1947.45

ng/l

0.37

3666

25760

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5453

40294

1.61

111.35

5.3

5.8

11.80

12.30

umol/l

2.07

5105

37990

(3009261) Glucose [Presence] in Urine by Test strip

4994

36225

1.60

109.33

5.0

4.4

0.00

estimate

1.08

1049

6261

(3035350) Ketones [Presence] in Urine by Test strip

4952

35859

1.60

109.10

5.0

4.4

0.00

estimate

0.32

1169

6994

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3905

26792

1.61

107.10

5.4

4.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

4927

35757

1.59

106.54

6.5

5.8

0.00

estimate

0.50

1057

6284

(40760892) CBC W Ordered Manual Differential panel - Blood

4542

32365

1.59

105.93

6.4

6.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3548

23873

1.62

104.77

2.6

2.5

58.92

64.01

u/l

0.77

3220

21741

(3013512) EKG study

3611

24402

1.62

104.76

5.0

4.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4068

28327

1.60

103.94

3.2

2.9

143.07

155.51

ug/l

1.95

3509

25230

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3358

22409

1.62

101.82

2.5

2.3

3.28

3.18

mg/l

1.43

2772

18795

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5212

38691

1.57

99.30

6.0

5.7

1.21

mmol/l

1.59

4549

34616

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5059

37537

1.55

94.70

3.4

3.1

59.36

56.15

u/l

0.95

4401

33418

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4909

36284

1.54

92.72

2.3

2.2

93.96

93.13

pmol/l

0.52

2446

18368

(3019309) Folate [Moles/volume] in Red Blood Cells

3009

20029

1.59

89.52

2.0

1.8

1220.00

1156.90

nmol/l

2.76

2144

14658

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3628

25362

1.55

86.30

2.3

2.1

182.86

221.77

u/l

2.15

3342

23455

(3024561) Albumin [Mass/volume] in Serum or Plasma

4876

36326

1.52

86.28

4.6

4.4

33.98

34.27

g/l

2.87

4368

33134

(3029937) Albumin [Presence] in Urine by Test strip

2946

19662

1.58

85.89

5.4

4.8

0.00

estimate

0.05

1005

6008

(3041096) Erythrocytes [Presence] in Urine by Automated

2697

17644

1.60

85.51

4.8

4.2

—

(3026008) Bacteria identified in Urine by Culture

4139

29846

1.53

84.92

4.0

3.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

3186

21799

1.55

82.55

1.6

20.78

20.34

nmol/l

0.71

2554

18302

(3006315) Basophils [#/volume] in Blood

4694

34890

1.51

82.55

5.5

5.3

0.04

e9/l

0.61

4023

29309

(3013650) Neutrophils [#/volume] in Blood by Automated count

5347

40878

1.50

81.71

8.1

8.4

4.54

4.38

e9/l

4.04

4677

35026

(3013115) Eosinophils [#/volume] in Blood

4803

35929

1.50

81.48

5.6

5.5

0.19

0.20

e9/l

0.47

4123

30584

(3001604) Monocytes [#/volume] in Blood

4669

34735

1.50

81.27

5.5

5.3

0.63

e9/l

0.40

4004

29161

(3019198) Lymphocytes [#/volume] in Blood

4750

35528

1.50

80.10

5.6

5.4

1.79

1.88

e9/l

1.09

4138

30487

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4208

30795

1.50

78.33

2.4

2.2

82.49

80.75

nmol/l

3.39

3527

26353

(3023368) Bacteria identified in Blood by Culture

3522

25111

1.50

72.92

4.2

4.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

4478

33557

1.47

71.78

6.2

5.9

24.40

25.47

7.69

4082

30839

(3019069) Monocytes/100 leukocytes in Blood

4419

33068

1.47

71.12

6.3

6.0

8.91

8.90

0.08

4037

30327

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2323

15238

1.57

70.38

1.9

—

(40761536) Microorganisms panel - Urine sediment

1096

5896

1.84

70.03

5.3

4.6

—

(3006504) Eosinophils/100 leukocytes in Blood

4392

32899

1.46

69.87

5.9

5.7

2.77

2.80

0.24

4003

30130

(3015736) pH of Urine

3945

28963

1.47

69.54

4.4

4.1

5.94

5.84

0.41

826

(3015377) Calcium [Moles/volume] in Serum or Plasma

3889

28501

1.47

69.02

3.0

3.2

2.35

2.36

mmol/l

3.68

3240

24005

(3022096) Basophils/100 leukocytes in Blood

4280

31961

1.46

68.84

6.0

5.7

0.64

0.23

3894

29267

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3948

29069

1.46

68.11

2.3

2.2

—

(3018010) Neutrophils/100 leukocytes in Blood

4389

32976

1.45

68.10

5.8

5.6

60.15

59.13

5.60

4009

30288

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1213

7001

1.72

60.39

3.9

3.8

1.22

1.23

mmol/l

3.56

986

6026

(3044889) 12 lead EKG panel

6149

49807

1.43

59.62

5.1

4.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1407

8488

1.65

59.19

4.3

3.9

—

(3020682) Albumin/Creatinine [Ratio] in Urine

3440

25176

1.44

58.70

3.9

3.6

11.86

8.93

mg/mmol

1.71

2027

15385

(3002385) Erythrocyte distribution width [Ratio]

6719

55460

1.44

57.57

24.0

21.9

15.72

15.61

0.77

6565

54255

(3012516) Albumin [Mass/volume] in Urine

3261

23699

1.44

57.50

3.3

3.1

467.51

395.64

mg/l

0.35

1948

14772

(3022948) Iron [Moles/volume] in Serum or Plasma

2041

13575

1.52

56.14

2.7

2.4

11.28

11.58

umol/l

1.06

1801

12373

(3009508) Creatinine [Moles/volume] in Urine

3252

23886

1.42

52.96

3.3

3.0

6.33

6.74

mmol/l

7.47

2517

19394

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1903

12607

1.52

52.92

2.7

2.4

2.27

2.26

g/l

0.37

1663

11449

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4403

34195

1.38

50.98

2.9

2.7

—

(1761868) Lipid panel - Serum or Plasma

2244

15553

1.46

49.41

3.7

3.5

—

(3023520) Reticulocytes [#/volume] in Blood

1357

8458

1.59

49.23

2.5

2.4

67.56

67.32

e9/l

0.08

1071

6407

(3018418) pH of Serum or Plasma

3406

25464

1.39

49.07

4.1

3.9

7.40

0.31

792

4511

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1794

11964

1.50

47.73

2.8

2.5

20.21

20.64

0.62

1419

9963

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

954

5518

1.69

46.45

4.0

3.7

5.21

5.17

kpa

0.69

873

5155

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2179

15198

1.45

45.88

1.7

1.45

1.56

mg/l

0.59

1702

11923

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

916

5260

1.70

45.79

4.0

3.6

1.87

2.09

mmol/l

0.89

666

3923

(3021589) Normoblasts [#/volume] in Blood

3887

29993

1.36

44.87

13.1

10.4

0.00

e9/l

0.42

3247

24175

(3018095) Leukocytes [#/volume] in Urine

3736

28668

1.36

44.61

4.2

4.1

151.26

133.87

e6/l

0.37

2827

20785

(3009343) pH of Capillary blood

936

5446

1.68

44.49

4.1

3.6

7.41

7.42

1.86

135

671

(3027945) Reticulocytes/100 erythrocytes in Blood

1680

11269

1.48

42.92

2.3

2.2

1.83

1.78

1.16

1376

9741

(3000850) Epithelial cells [#/volume] in Urine

2481

17947

1.40

41.96

3.0

2.7

5.43

5.29

e6/l

0.15

2219

16009

(3019225) pH of Specimen

1378

8997

1.51

39.89

5.1

4.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2621

19270

1.38

39.82

2.9

8490.48

7069.73

umol/l

0.61

2124

16111

(3019150) Specific gravity of Urine by Refractometry

2274

16334

1.40

39.71

5.5

4.9

1.02

kg/l

0.41

424

2616

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3255

24809

1.35

39.16

5.9

5.7

4.19

4.68

ug/l

0.19

2790

21713

(3026782) Osmolality of Urine

2399

17431

1.39

39.01

3.3

3.2

510.23

534.60

mosm/kgh2o

7.52

2032

14869

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

693

3850

1.74

38.83

2.0

—

(3002582) Erythrocytes [#/volume] in Urine

3312

25368

1.34

38.35

3.7

3.5

157.39

100.13

e6/l

0.57

2627

19630

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

647

3548

1.76

37.92

1.9

1.8

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1304

8601

1.49

35.62

2.6

2.5

4.78

6.19

ug/l

4.67

1032

7137

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1730

12057

1.42

35.34

1.3

1.2

1.74

1.87

u/ml

0.14

439

2742

(3030467) Casts [#/volume] in Urine by Automated count

3038

23287

1.33

33.94

3.5

3.4

0.45

0.52

e6/l

0.88

2416

18006

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1587

10974

1.43

33.70

5.4

4.7

1.06

1.04

mmol/l

3.02

1406

9917

(40767503) Oxygen content in Capillary blood by calculation

378

1816

1.99

33.45

2.6

15.62

15.67

0.08

184

962

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

681

3922

1.68

33.34

1.9

1.8

3.46

2.42

ug/l

0.52

559

3347

(40768804) Tissue Pathology biopsy report

3596

28299

1.31

33.00

2.4

2.3

—

(3017181) Myelocytes/100 leukocytes in Blood

976

6161

1.54

32.65

4.1

3.7

0.96

0.01

382

2322

(3021440) Promyelocytes/100 leukocytes in Blood

932

5831

1.56

32.45

4.1

3.7

0.11

0.10

0.26

341

2009

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1509

10419

1.43

32.17

9.8

8.8

—

(3025159) Blasts/100 leukocytes in Blood

876

5425

1.57

31.88

4.2

3.7

0.12

0.45

1.95

285

1653

(3044640) Blood type and Crossmatch panel - Blood

3191

24875

1.30

30.84

2.7

2.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

1298

8787

1.45

30.69

1.9

1.8

—

(3002179) Metamyelocytes/100 leukocytes in Blood

885

5551

1.55

30.39

4.1

3.6

0.71

0.67

0.16

335

1975

(3028271) Lactate [Moles/volume] in Capillary blood

294

1344

2.09

29.82

2.0

1.9

1.65

1.70

mmol/l

0.47

283

1311

(3022313) Gas panel - Capillary blood

664

3924

1.63

29.33

4.3

3.8

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2314

17348

1.33

29.28

3.0

3.1

2.47

mmol/l

0.02

2031

14864

(40761535) Cells panel - Urine sediment

1088

7197

1.47

28.90

4.1

3.7

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

573

3298

1.67

28.05

4.5

4.1

24.86

25.04

mmol/l

0.70

499

2953

(36304419) Bacteria [Presence] in Urine

2857

22185

1.30

27.73

3.5

3.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

755

4670

1.56

27.50

3.7

3.3

25.25

25.24

mmol/l

0.02

738

4540

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1797

13112

1.35

26.97

2.7

0.82

0.81

mmol/l

0.82

1614

11972

(3025941) Bacteria identified in Stool by Culture

579

3387

1.64

26.60

1.3

—

(3013290) Carbon dioxide [Partial pressure] in Blood

371

1927

1.84

25.99

4.6

4.2

5.07

5.01

kpa

0.68

361

1867

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1478

10516

1.38

25.93

3.4

3.7

246.67

250.66

u/l

0.43

1344

9807

(3036481) Cortisol [Moles/volume] in Serum or Plasma

908

5922

1.49

25.77

2.0

2.1

373.96

385.62

nmol/l

0.83

794

5296

(3012501) Base excess in Blood by calculation

370

1926

1.84

25.74

4.6

4.2

2.71

2.85

mmol/l

0.39

260

1327

(3019060) Gas panel - Arterial blood

936

6146

1.48

25.67

4.2

—

(3027315) Oxygen [Partial pressure] in Blood

371

1942

1.83

25.36

4.6

4.2

8.29

8.28

kpa

0.03

361

1881

(3017732) Neutrophils [#/volume] in Blood

720

4491

1.55

25.22

3.4

5.95

5.52

e9/l

0.23

454

3229

(3010421) pH of Blood

408

2205

1.77

25.07

4.7

4.0

7.42

1.14

380

1995

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

985

6625

1.44

23.76

1.7

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

833

5434

1.48

23.55

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1360

9688

1.37

23.49

5.1

4.9

35.16

34.07

2.83

854

6078

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1462

10631

1.34

21.99

1.8

—

(3042936) Bacteria identified in Isolate by Culture

1514

11071

1.34

21.92

2.0

1.9

—

(3022806) Fractional oxyhemoglobin in Capillary blood

230

1078

2.03

21.91

2.0

1.8

89.11

88.96

0.15

225

1061

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

299

1540

1.85

21.56

1.2

1.3

151.43

170.27

titre

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1462

10666

1.34

21.46

1.8

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

858

5735

1.45

21.32

6.2

6.1

24.60

24.65

mmol/l

0.15

818

5441

(40768797) Stomach Pathology biopsy report

1377

9988

1.34

20.98

1.3

1.2

—

(3012544) pH of Venous blood

1239

8850

1.36

20.86

3.6

3.4

7.38

7.39

0.16

(3048689) Calprotectin [Mass/mass] in Stool

924

6299

1.42

20.58

2.1

1.9

233.00

166.59

ug/g

1.37

672

4790

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1011

7003

1.40

20.54

3.5

3.3

97.35

94.97

ng/l

0.31

791

5793

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1194

8547

1.36

19.76

3.6

3.4

5.85

5.84

kpa

0.15

1159

8265

(3002032) Base excess in Venous blood by calculation

1193

8539

1.36

19.76

3.6

3.4

2.13

1.99

mmol/l

0.66

1013

7218

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2399

18861

1.26

19.68

2.7

2.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2187

17011

1.27

19.64

1.6

1.28

mmol/l

0.07

1641

13985

(3020630) Protein [Mass/volume] in Serum or Plasma

1125

7987

1.37

19.62

2.5

2.4

65.88

65.69

g/l

0.35

970

6995

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2561

20295

1.25

19.59

3.0

35.06

36.49

u/l

0.28

2359

18915

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

669

4344

1.48

19.28

4.4

4.1

45.14

46.53

0.80

662

4291

(3015235) Bicarbonate [Moles/volume] in Capillary blood

402

2328

1.65

19.22

3.2

3.1

25.12

25.05

mmol/l

0.11

393

2278

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

871

5952

1.41

19.09

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2500

19816

1.25

18.97

5.0

4.9

21.93

22.36

0.74

1443

10850

(1616796) Gas panel - Central venous blood

346

1941

1.70

18.68

4.0

3.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1426

10593

1.31

18.19

1.5

2.83

2.69

g/l

1.05

786

5599

(3020891) Body temperature

560

3550

1.51

18.14

4.5

4.3

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

133

542

2.32

18.07

1.1

2.12

2.29

iu/ml

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

843

5788

1.40

17.96

3.1

2.8

54.01

57.41

ml/min/173m2

2.38

427

2589

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1253

9161

1.33

17.89

3.5

3.1

254.43

258.57

ng/l

0.10

1162

8399

(3000494) Fungus identified in Specimen by Culture

1084

7760

1.35

17.84

1.4

—

(3021901) Oxygen saturation in Capillary blood

313

1740

1.71

17.49

2.8

2.9

—

(3003338) MCHC [Mass/volume]

5997

52172

1.21

17.26

28.1

25.1

329.89

330.22

g/l

2.03

5923

51457

(3004588) Protein electrophoresis panel - Serum or Plasma

950

6700

1.37

17.18

2.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1339

9938

1.31

17.11

1.3

33.92

42.26

iu/ml

1.67

452

3039

(3037522) Nuclear Ab [Titer] in Serum

1051

7547

1.35

16.91

1.3

594.39

517.11

titre

0.67

285

1754

(3000012) Reticulocyte production index

269

1448

1.77

16.85

1.9

2.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

685

4588

1.43

16.76

3.2

2.9

0.36

0.33

e6/l

0.19

674

4493

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

729

4944

1.42

16.64

2.6

2.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2191

17346

1.24

16.40

4.8

4.2

231.10

415.53

ng/l

1.78

1925

15315

(3028626) Oxygen [Partial pressure] in Capillary blood

345

2013

1.63

16.06

2.8

2.9

7.71

7.74

kpa

0.11

335

1963

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1689

13062

1.26

15.45

1.9

30.08

30.05

0.05

1619

12659

(3006184) Hemoglobin [Mass/volume] in Capillary blood

347

2058

1.61

15.14

2.3

126.98

125.07

g/l

0.72

257

1478

(3016502) Oxygen saturation in Arterial blood

1247

9320

1.30

15.00

5.1

6.0

94.96

95.25

0.74

1191

8909

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

494

3182

1.48

14.82

2.7

—

(3024354) Oxygen [Partial pressure] in Venous blood

979

7094

1.33

14.74

3.2

2.9

4.28

4.34

kpa

0.39

948

6832

(3022145) Colonoscopy Study observation

1035

7561

1.32

14.72

1.3

—

(3003396) Base excess in Arterial blood by calculation

1377

10452

1.28

14.65

5.1

5.8

1.25

1.22

mmol/l

0.09

1071

8204

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

405

2513

1.54

14.53

1.5

1.6

265.00

251.42

titre

0.07

130

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1242

9316

1.29

14.51

1.3

1.2

17.54

16.74

u/ml

0.10

434

2991

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1013

7395

1.32

14.47

2.1

2.0

0.19

0.20

g/l

0.91

911

6781

(3037121) Protein [Mass/volume] in Urine

458

2922

1.50

14.41

3.0

2.7

0.33

0.28

g/l

0.57

179

1078

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

464

2972

1.49

14.32

1.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

788

5554

1.36

14.25

3.4

3.1

124.37

126.12

g/l

1.54

764

5413

(3022621) pH of Urine by Test strip

772

5431

1.36

14.13

3.9

3.6

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1375

10490

1.27

13.99

5.1

5.8

5.02

5.07

kpa

0.90

1292

9886

(3011397) Hemoglobin [Presence] in Urine by Test strip

2249

18114

1.22

13.91

4.8

4.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1373

10486

1.27

13.83

5.1

5.8

11.38

11.78

kpa

2.25

1296

9863

(3009445) Proteinase 3 Ab [Units/volume] in Serum

499

3270

1.46

13.73

1.5

34.66

20.37

u/ml

0.42

(3018405) Lactate [Moles/volume] in Arterial blood

489

3194

1.46

13.69

3.5

3.6

1.36

1.43

mmol/l

0.70

477

3135

(3007930) Methemoglobin/Hemoglobin.total in Blood

566

3807

1.42

13.53

4.6

0.88

0.86

0.41

536

3574

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

570

3868

1.41

12.96

4.6

4.5

1.61

1.56

0.79

539

3634

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

282

1670

1.60

12.44

1.7

1.5

6.19

7.88

iu/ml

0.10

434

(4146454) Self-monitoring of blood glucose

174

907

1.82

12.26

2.9

2.4

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1030

7714

1.28

12.08

7.1

5.6

12.43

11.51

mmol/l

2.95

947

7199

(3005719) IgG [Mass/volume] in Serum or Plasma

660

4645

1.36

12.04

3.0

2.7

10.72

10.58

g/l

0.26

592

4195

(3004451) EKG impression Narrative

103

451

2.16

11.94

1.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

238

1367

1.65

11.89

3.2

3.4

59.75

59.18

0.25

238

1367

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

309

1893

1.55

11.81

2.3

2.1

121.13

98.39

ug/min

0.41

166

1038

(3000570) Elastase.pancreatic [Mass/mass] in Stool

355

2245

1.50

11.72

1.4

262.40

265.37

ug/g

0.10

216

1355

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

676

4799

1.35

11.66

5.2

5.8

24.69

24.95

mmol/l

1.00

668

4741

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

303

1862

1.55

11.43

1.4

1.5

—

(3043409) Potassium [Moles/volume] in Arterial blood

416

2733

1.45

11.34

3.7

3.8

3.86

3.90

mmol/l

0.63

411

2700

(3028026) IgM [Mass/volume] in Serum or Plasma

533

3675

1.38

11.06

1.7

1.9

1.25

1.45

g/l

1.18

468

3225

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

240

1418

1.61

10.75

1.3

1.2

30.43

3.72

u/ml

0.87

152

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

242

1435

1.60

10.68

1.3

1.2

5.50

4.64

u/ml

0.18

233

(1761482) Bacteria [#/volume] in Urine by Culture

417

2775

1.43

10.63

5.1

5.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1091

8372

1.25

10.41

5.5

6.4

118.04

118.89

g/l

0.76

1063

8126

(3027923) C peptide [Moles/volume] in Serum or Plasma

307

2.31

10.29

1.4

1.2

1.01

1.21

nmol/l

0.96

229

(40768443) Skin Pathology biopsy report

502

3478

1.38

10.13

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

481

3312

1.38

10.09

2.7

2.9

47.94

86.45

mg/l

1.28

371

2694

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

480

3304

1.38

10.08

2.7

3.0

55.83

54.70

mg/l

0.03

374

2690

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

468

3217

1.39

9.92

2.7

2.9

2.07

2.55

ratio

0.25

224

(3014271) Vancomycin [Susceptibility]

141

739

1.80

9.86

3.2

3.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

250

1532

1.55

9.62

1.3

1.2

23.31

44.96

u/ml

1.00

(3003181) Sodium [Moles/volume] in Urine

285

1799

1.50

9.56

1.4

1.3

61.46

60.68

mmol/l

0.13

234

1442

(3047181) Lactate [Moles/volume] in Blood

400

2708

1.40

9.30

5.6

5.4

1.30

1.36

mmol/l

0.51

362

2398

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

348

2305

1.43

9.15

1.5

1.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

447

3093

1.38

9.12

2.1

574.45

548.67

ug/l

0.08

413

2900

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

205

1232

1.58

8.64

1.2

3.55

8.71

u/ml

1.15

(3000330) Specific gravity of Urine by Test strip

642

4732

1.29

8.51

4.5

4.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

198

1185

1.58

8.50

1.3

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

276

1776

1.47

8.47

1.5

—

(4034850) Laboratory test

345

2318

1.41

8.41

14.1

13.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

502

3585

1.33

8.37

3.4

3.0

4.27

4.29

pmol/l

0.18

407

3062

(3020961) Endomysium IgA Ab [Titer] in Serum

335

2243

1.42

8.33

1.2

1.1

148.13

240.82

titre

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

269

1736

1.47

8.15

1.4

1.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

234

1469

1.51

8.13

3.1

3.5

1.74

1.49

0.39

198

1256

(4200892) Spirometry reversibility

700

5250

1.27

8.10

1.4

—

(3002256) Pathology report gross observation

1223

9742

1.21

8.08

1.4

—

(3037756) Immunofixation for Serum or Plasma

324

2170

1.42

8.06

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

414

2893

1.36

7.99

3.4

3.3

0.86

0.81

nmol/l

0.94

329

2241

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

320

2143

1.42

7.97

1.5

9.67

20.50

iu/ml

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

213

1321

1.53

7.85

1.3

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

129

708

1.72

7.80

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

247

2.25

7.78

1.3

1.2

15.63

10.72

umol/l

0.40

170

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

732

5550

1.26

7.74

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1684

13850

1.17

7.68

3.5

3.4

0.84

0.85

ug/l

0.27

1263

10214

(3008757) Leukocyte morphology finding [Identifier] in Blood

162

949

1.61

7.65

3.7

4.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

177

1060

1.58

7.63

1.4

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

213

1331

1.52

7.59

3.6

2.9

—

(3018572) Chloride [Moles/volume] in Blood

288

1914

1.43

7.51

6.1

6.0

104.69

104.90

mmol/l

0.28

262

1703

(3039000) Anion gap in Blood

288

1914

1.43

7.51

6.1

6.0

11.24

11.28

mmol/l

0.08

262

1703

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

259

1688

1.45

7.50

3.0

2.5

1.96

1.81

mg/l

1.50

221

1474

(3015171) Extractable nuclear Ab [Units/volume] in Serum

318

2152

1.40

7.48

1.3

1.2

0.82

0.94

u/ml

0.10

218

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1769

14635

1.17

7.47

3.0

1.31

1.33

e6/l

0.05

1089

8538

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

180

1093

1.56

7.32

1.3

—

(3003694) ABO and Rh group [Type] in Blood

1920

16006

1.16

7.32

1.3

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

102

535

1.80

7.24

1.2

96.20

85.46

u/ml

—

(3042631) Mycobacterium sp identified in Specimen

207

1300

1.51

7.23

2.7

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

203

1270

1.51

7.22

1.2

9.67

4.86

u/ml

—

(3004616) Nuclear Ab [Presence] in Serum

138

789

1.65

7.20

1.2

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

198

1234

1.52

7.17

2.2

2.1

29.24

26.78

mg/l

0.18

299

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

267

1766

1.43

7.16

1.9

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

341

2353

1.38

7.16

1.7

1.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

262

1729

1.44

7.12

1.7

1.4

0.23

g/l

0.24

250

1603

(3017354) Segmented neutrophils/100 leukocytes in Blood

155

916

1.60

7.10

3.1

3.5

60.13

57.59

0.67

121

741

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

102

539

1.79

7.07

1.2

57.47

40.23

u/ml

—

(3049717) Cytology report of Urine Cyto stain

525

3865

1.29

7.07

2.8

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1210

9749

1.19

7.03

3.1

3.8

18.49

21.95

ug/l

0.28

1010

8096

(3045424) Erythrocytes [Presence] in Urine

194

1210

1.52

7.01

1.5

—

(44813793) Dust mix specific IgE antibody measurement

284

2.09

6.97

1.0

1.1

—

(3044927) Protein electrophoresis panel - Urine

172

1049

1.55

6.89

1.2

—

(3045414) Leukocytes [Presence] in Urine

462

3359

1.31

6.84

2.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

168

1022

1.55

6.81

1.3

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

410

1.89

6.80

1.6

1.9

102.94

92.21

umol/l

0.84

410

(46235355) HIV 1 and 2 tests - Meaningful Use set

664

5067

1.25

6.66

1.5

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

362

2555

1.34

6.61

1.6

39.44

38.25

u/l

0.42

300

2113

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

265

1780

1.41

6.56

1.8

1.4

1.10

1.16

g/l

2.17

253

1656

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

183

1149

1.51

6.45

1.3

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

185

1165

1.50

6.43

1.7

1.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

623

4740

1.25

6.42

1.7

1.6

1.53

1.59

g/l

0.78

520

4010

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

178

1113

1.51

6.40

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

408

2949

1.31

6.33

1.1

1.2

94.10

125.49

iu/ml

1.18

137

965

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

149

898

1.57

6.33

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

163

1006

1.53

6.24

1.6

1.5

62.86

62.91

0.01

105

629

(3033705) Calcium.ionized [Moles/volume] in Venous blood

218

1428

1.44

6.22

2.5

—

(40758558) Short blood count panel - Blood

2150

18264

1.14

6.12

6.0

6.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

596

4542

1.25

6.07

1.5

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

213

1397

1.44

6.05

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

135

807

1.58

5.96

1.2

250.78

270.01

pmol/l

0.51

115

676

(40760888) Immunoglobulin light chains.free panel - Serum

347

2474

1.33

5.96

2.8

3.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

135

808

1.58

5.94

1.3

1.2

—

nmol/l

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

479

1.75

5.88

3.6

3.7

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

203

2.18

5.85

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

184

1184

1.47

5.79

1.4

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

609

4683

1.24

5.73

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

169

1073

1.49

5.69

1.5

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

555

1.68

5.67

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

165

1044

1.49

5.66

1.5

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

506

1.72

5.65

1.1

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

166

1056

1.49

5.55

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

164

1043

1.49

5.50

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

164

1043

1.49

5.50

1.5

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

332

1.87

5.45

1.1

1.2

1.06

0.97

promille

0.20

250

(3014111) Lactate [Moles/volume] in Serum or Plasma

965

7794

1.18

5.44

4.5

5.4

1.38

1.40

mmol/l

0.23

935

7532

(3005988) Vibrio sp identified in Specimen by Organism specific culture

164

1046

1.48

5.42

1.5

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

258

1794

1.36

5.27

2.8

2.9

236.72

717.92

u/ml

1.78

229

1622

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

487

3692

1.25

5.24

2.5

2.4

14.45

26.38

au/ml

1.78

167

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

309

2215

1.32

5.16

1.5

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1620

13659

1.14

5.11

3.3

3.2

3.09

3.02

e6/l

0.08

953

7628

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

347

2533

1.30

5.08

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

169

1100

1.45

5.07

7.5

8.2

7.53

7.28

mmol/l

0.41

140

900

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

473

1.70

5.05

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

236

1633

1.37

5.00

1.8

1.7

13.05

12.43

mg/l

0.12

215

1457

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

169

1104

1.45

4.98

1.3

1.4

0.79

0.83

nmol/l

0.36

132

903

(3023183) Ammonium ion [Moles/volume] in Plasma

222

1522

1.38

4.98

2.1

2.0

32.72

32.14

umol/l

0.13

184

1309

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

475

1.69

4.98

1.4

—

(3023419) Bacteria identified in Sputum by Culture

196

1316

1.41

4.97

2.3

2.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

437

3302

1.26

4.86

1.3

47.18

63.04

au/ml

0.89

174

(3014148) Varicella zoster virus Ab [Titer] in Serum

298

1.87

4.86

1.1

—

(3021788) Differential panel - Synovial fluid

218

1498

1.38

4.83

1.5

1.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

121

744

1.54

4.81

1.4

13.75

13.30

u/l

0.35

116

708

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

295

2126

1.31

4.77

1.5

1.6

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.64

4.77

1.1

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

145

930

1.47

4.72

1.3

1.2

0.71

0.68

nmol/l

0.53

136

887

(3020876) Protein [Mass/time] in 24 hour Urine

146

940

1.47

4.67

2.0

2.2

1.09

1.07

g/24h

0.04

419

(40757494) Bilirubin.total [Moles/volume] in Blood

434

1.69

4.67

2.1

2.0

15.62

25.13

umol/l

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

499

3852

1.23

4.59

2.0

2.2

3.64

3.68

g/l

0.24

421

3334

(3000991) Gas panel - Venous blood

901

7353

1.17

4.49

5.3

6.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

499

3862

1.23

4.49

2.0

2.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

497

1.63

4.47

1.2

—

(3004775) Volume in Urine collected for unspecified duration

107

652

1.55

4.46

2.7

2.1

666.11

647.02

0.20

414

(3016750) Collection duration of Urine

447

1.67

4.46

2.4

2.0

487.57

497.89

min

0.38

321

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

499

3867

1.22

4.43

2.1

2.2

7.64

7.57

g/l

0.41

421

3340

(3043410) Blood group antigens tested for on Red Blood Cells

208

1.99

4.42

1.5

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

173

1164

1.40

4.39

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

173

1164

1.40

4.39

1.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.75

4.37

2.3

4.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

181

1229

1.39

4.36

1.3

1.2

—

(3010503) CD19 cells [#/volume] in Blood

372

1.72

4.35

2.1

1.9

0.11

0.17

e9/l

0.57

351

(3005322) IgE [Units/volume] in Serum or Plasma

381

2874

1.26

4.34

1.3

191.69

222.92

u/ml

0.39

350

2589

(3022493) Free Hemoglobin [Mass/volume] in Plasma

331

1.77

4.32

2.5

3.2

69.59

66.88

mg/l

0.10

227

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

143

933

1.45

4.30

1.3

1.2

0.16

0.25

nmol/l

1.14

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

133

856

1.47

4.30

2.7

2.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

109

674

1.53

4.27

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

109

674

1.53

4.27

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

109

674

1.53

4.27

1.5

—

(3011985) Renin [Units/volume] in Plasma

135

874

1.46

4.24

1.2

1.3

26.02

55.78

mu/l

3.97

118

771

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

153

1019

1.42

4.14

1.3

1.2

32.90

53.72

u/ml

1.46

115

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

190

1315

1.37

4.10

1.1

34.95

13.40

u/ml

—

(3006270) Folate [Moles/volume] in Blood

124

796

1.47

4.08

1.3

1.2

279.62

315.02

nmol/l

1.16

580

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

131

852

1.45

4.04

1.6

1.5

—

(3000285) Sodium [Moles/volume] in Blood

127

2.22

4.02

1.4

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

514

4038

1.21

4.01

1.7

1.5

1.68

1.61

0.96

408

3246

(3017446) Testosterone [Moles/volume] in Serum or Plasma

440

3404

1.22

4.01

2.0

11.82

10.67

nmol/l

1.46

337

2863

(3051593) INR in Capillary blood by Coagulation assay

542

1.57

3.99

10.7

11.8

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

128

2.21

3.95

1.0

1.1

1727.30

1617.70

miu/ml

0.20

128

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

507

1.58

3.94

2.4

2.3

—

(36660697) Celiac disease serology panel - Serum

553

4387

1.20

3.89

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

186

1.97

3.87

1.9

2.3

7.18

7.36

mmol/l

0.08

127

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.40

3.83

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

214

1.89

3.78

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

214

1.89

3.78

1.1

1.06

1.10

ratio

0.86

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

2.95

3.76

1.1

0.67

1.11

u/field

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

109

695

1.48

3.74

1.5

1.4

—

(3014007) Fractional oxyhemoglobin in Arterial blood

677

5485

1.17

3.74

5.7

7.1

93.20

93.70

0.99

671

5463

(3041918) Cholesterol [Moles/volume] in Pleural fluid

183

1.96

3.69

1.1

1.2

1.16

1.53

mmol/l

1.52

109

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

130

862

1.42

3.65

1.3

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

473

1.57

3.63

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

473

1.57

3.63

1.3

1.4

—

(3046861) Legionella sp Ag [Presence] in Urine

3.14

3.63

1.0

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

167

1157

1.36

3.63

4.1

3.8

326.21

2917.44

iu/ml

0.97

164

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

154

1058

1.37

3.53

1.3

397.10

406.30

u/l

0.02

141

991

(3013139) Helicobacter pylori Ag [Presence] in Stool

547

4379

1.18

3.51

1.2

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

370

1.63

3.42

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

335

1.66

3.38

1.4

1.5

5.09

6.56

u/l

1.53

269

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

408

1.59

3.37

1.7

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

409

1.59

3.34

1.7

1.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

105

682

1.45

3.33

1.5

1.4

—

(3016038) Potassium [Moles/volume] in Urine

102

661

1.46

3.28

1.1

31.15

35.58

mmol/l

1.51

537

(3028679) Herpes simplex virus Ab [Presence] in Serum

165

1.94

3.26

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

251

1871

1.27

3.26

4.7

3.7

30.65

30.27

mg/l

0.05

156

1252

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

123

827

1.40

3.24

1.3

12.84

12.77

u/l

0.01

111

747

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

362

1.61

3.21

1.1

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

135

2.02

3.13

1.2

1.3

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

8.06

3.13

1.2

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

209

1.80

3.09

1.6

1.4

18.15

17.30

pmol/l

0.30

164

(3003327) Ova and parasites identified in Stool by Light microscopy

226

1676

1.27

3.08

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

124

843

1.39

3.08

3.7

3.6

321.27

329.61

umol/l

0.27

684

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

448

3569

1.19

3.08

2.1

2.2

2.95

3.02

g/l

0.61

368

3044

(3000475) Leukocytes [#/volume] in Synovial fluid

270

2047

1.25

3.06

1.7

1.6

13676.46

15310.62

e6/l

0.32

217

1434

(3039162) Centromere protein B Ab [Units/volume] in Serum

103

679

1.43

3.05

1.3

1.2

50.74

52.17

u/ml

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.66

2.98

1.0

1.1

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

670

5526

1.15

2.98

5.6

7.0

0.69

0.67

0.68

659

5481

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

138

1.98

2.97

1.1

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

672

5548

1.15

2.95

5.6

6.9

1.41

1.33

1.16

661

5501

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

132

2.00

2.94

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

132

2.00

2.94

1.1

1.2

35.59

323.59

u/l

0.58

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

356

1.59

2.94

1.3

1.4

1.07

0.93

u/ml

0.06

209

(3010144) Erythrocytes [#/volume] in Synovial fluid

118

804

1.38

2.92

1.4

202701.33

189039.15

e6/l

0.05

545

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

119

813

1.38

2.90

2.0

2.4

3.12

2.25

u/field

0.44

270

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

189

1383

1.29

2.89

1.6

6.01

4.73

iu/l

0.53

398

(21494814) CD8 cells/100 lymphocytes in Specimen

242

1.71

2.88

2.0

1.8

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

153

1090

1.32

2.85

6.6

6.1

12.53

12.60

mg/l

0.06

134

968

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

452

3633

1.18

2.83

2.1

2.2

10.28

10.22

g/l

0.07

371

3075

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

117

801

1.38

2.82

1.2

60.73

62.61

u/l

0.11

100

714

(3024980) IgG subclass 4 [Mass/volume] in Serum

121

834

1.37

2.80

1.2

1.6

0.87

0.85

g/l

0.05

627

(44816559) Phosphatidylethanol [Mass/volume] in Blood

103

691

1.41

2.80

1.4

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

216

1.74

2.80

2.1

1.7

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

535

1.46

2.80

1.3

0.41

0.48

g/l

0.63

381

(3028192) IgG subclass 2 [Mass/volume] in Serum

535

1.46

2.80

1.3

2.79

2.88

g/l

0.19

380

(3027135) IgG subclass 1 [Mass/volume] in Serum

535

1.46

2.80

1.3

6.76

7.22

g/l

0.57

376

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

113

771

1.38

2.79

1.4

1.5

25.43

27.34

0.24

485

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

117

803

1.37

2.78

1.4

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

183

1.80

2.73

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

3.05

2.71

2.8

3.4

—

(3032057) Clostridioides difficile [Presence] in Stool

233

1.70

2.69

1.9

1.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

233

1.70

2.69

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

277

1.63

2.66

1.0

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

234

1.69

2.65

1.3

1.4

17.76

22.72

umol/l

0.67

220

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

139

1.90

2.58

1.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

160

1167

1.29

2.55

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

246

1.65

2.48

1.1

1.2

126.33

154.70

mmol/24h

1.65

246

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

131

935

1.32

2.46

1.1

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

388

1.51

2.46

1.2

1.1

27.13

31.05

u/l

0.29

343

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

115

1.96

2.45

2.3

2.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

258

2001

1.22

2.44

1.3

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

489

1.44

2.43

1.3

1.2

1.49

1.48

nmol/l

0.03

441

(3016228) CD19 cells/100 cells in Blood

255

1.62

2.42

2.0

1.8

8.70

7.62

0.26

242

(3014765) Yersinia sp identified in Stool by Organism specific culture

261

2028

1.22

2.42

1.3

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

390

1.50

2.41

1.2

1.1

99.62

88.03

u/l

0.46

346

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

263

1.61

2.40

1.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

116

1.95

2.40

2.3

2.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.17

2.38

1.1

—

(3019977) pH of Arterial blood

539

1.42

2.36

2.1

2.3

7.42

0.09

199

(3007566) Smooth muscle Ab [Titer] in Serum

192

1449

1.25

2.35

1.2

1.1

80.00

171.16

titre

1.99

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.62

2.35

1.2

1.3

1.00

1.26

u/field

—

(3035880) pH of Pleural fluid

611

1.39

2.34

1.2

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

261

2036

1.21

2.34

1.3

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

265

1.60

2.34

1.5

1.4

19.56

21.56

0.21

216

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

117

829

1.33

2.33

1.7

21.77

26.76

u/ml

0.82

184

(3008295) Osmolality of Serum or Plasma

117

830

1.33

2.31

1.5

1.3

276.86

274.47

mosm/kgh2o

0.51

586

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

772

6543

1.12

2.29

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

185

1395

1.25

2.29

1.3

1.5

5091.83

2169.61

e6/l

0.41

140

981

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

403

1.47

2.27

2.0

1.8

—

(3000492) Spirometry study

600

5015

1.13

2.25

1.5

1.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.14

2.23

2.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

367

1.49

2.21

1.3

1.2

179.17

262.24

u/l

0.88

343

(3034770) Mitochondria Ab [Titer] in Serum

193

1469

1.24

2.21

1.2

1.1

621.67

896.30

titre

—

(3017704) Immunofixation for Urine

531

1.40

2.20

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.00

2.18

1.4

1.5

45.15

47.62

umol/l

0.20

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

176

1.71

2.17

1.1

—

17.11

u/ml

—

(3014051) Protein [Presence] in Urine by Test strip

273

2157

1.19

2.16

3.1

2.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

340

1.50

2.12

1.4

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.27

2.12

1.3

1.7

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

129

1.82

2.10

3.1

2.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

178

1.69

2.09

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

143

1.78

2.09

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

205

1583

1.22

2.07

1.4

1.5

29.54

31.21

g/l

1.19

192

1385

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.27

2.07

1.3

1.5

—

(4062490) Immunoglobulin typing, IgG

539

1.38

2.04

1.3

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

289

2313

1.18

2.00

1.3

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

152

1143

1.25

1.98

1.1

—

(3017569) Oxygen content in Arterial blood

463

1.40

1.98

1.9

2.1

—

(3033658) Prothrombin time (PT) actual/Normal

2144

19136

1.07

1.95

3.8

3.9

83.63

83.16

0.35

2095

18654

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

417

1.42

1.95

1.4

68.13

66.47

0.14

333

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

226

1.58

1.95

1.1

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

161

1.69

1.93

2.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

964

8346

1.09

1.92

2.5

9.44

9.82

umol/l

0.18

804

7170

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

105

757

1.31

1.91

1.3

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

105

757

1.31

1.91

1.3

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

124

914

1.28

1.91

1.4

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

220

1.58

1.90

1.2

1.1

—

(3006462) Nitrate [Presence] in Urine

404

1.42

1.89

4.8

4.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.92

1.88

1.3

1.1

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

4.27

1.84

1.0

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

161

1231

1.23

1.83

1.4

199.89

262.43

pmol/l

0.86

152

1190

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

176

1360

1.22

1.81

1.4

1.3

43.14

41.71

u/l

0.06

138

1176

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

153

1166

1.24

1.80

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

338

1.45

1.80

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.92

1.80

1.1

1.3

4268.82

152.66

ng/l

0.47

(3000919) Neutrophils/100 leukocytes in Pleural fluid

315

1.46

1.79

1.3

1.4

11.77

18.63

1.70

281

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

634

1.32

1.79

1.1

—

21.34

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

104

758

1.29

1.77

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

301

1.47

1.75

1.3

1.2

40.34

40.04

g/l

0.04

147

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

325

1.45

1.74

1.9

1.8

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

365

1.42

1.72

5.8

6.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

721

1.29

1.71

1.6

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

319

1.45

1.69

3.1

2.8

—

(3008898) HLA-B27 [Presence]

126

948

1.25

1.68

1.0

—

(40757373) Influenza virus identified in Isolate

205

1.56

1.68

1.2

1.3

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

2.06

1.67

1.3

1.1

11.68

23.99

pmol/l

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

336

1.43

1.66

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

147

1.66

1.65

1.1

—

(4035726) Immunohistochemistry procedure

804

6959

1.09

1.65

1.4

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

134

1019

1.24

1.64

1.3

6.65

6.31

mmol/l

0.65

128

934

(4094501) Cardiovascular stress test using bicycle ergometer

212

1687

1.19

1.63

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

3.13

1.63

1.0

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

215

1.53

1.61

1.7

2.0

138444.29

45861.45

u/ml

—

(3044941) Cell count panel - Synovial fluid

169

1320

1.21

1.60

1.4

—

(1002224) Polysomnography panel

141

1084

1.23

1.57

1.0

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

525

1.33

1.57

1.8

189.75

182.25

pmol/l

0.28

477

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.63

1.53

1.1

1.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

223

1795

1.17

1.52

1.3

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

183

1449

1.19

1.52

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.84

1.51

1.4

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

144

1.63

1.51

1.1

1.0

102.06

90.64

0.98

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

473

1.33

1.48

2.0

2.1

2.13

1.80

u/field

0.20

304

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

449

1.34

1.48

1.2

2.11

2.26

mmol/l

0.79

409

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

713

1.27

1.47

1.1

1.54

1.58

g/l

0.44

627

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.24

1.47

1.2

1.1

—

(40768446) Kidney Pathology biopsy report

175

1.56

1.46

1.6

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

483

4106

1.11

1.46

3.2

3.5

24.07

24.19

mmol/l

0.38

469

3966

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

547

4682

1.10

1.45

6.8

7.8

—

(3048879) Bone marrow aspiration report

315

1.40

1.43

1.3

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

199

1.51

1.42

1.1

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

169

1.56

1.41

1.7

1.4

121.75

128.07

ng/l

0.10

169

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

349

1.38

1.39

2.0

1.9

516.00

507.37

e6/l

0.04

293

(3052592) Norovirus Ag [Presence] in Stool

224

1.47

1.37

1.4

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

206

1666

1.17

1.36

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

343

2877

1.12

1.34

1.3

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

320

1.38

1.33

1.9

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

320

1.38

1.33

1.9

1.8

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

190

1532

1.17

1.31

1.2

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

475

1.31

4.8

5.0

187.49

120.70

u/ml

0.29

138

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

102

776

1.24

1.30

1.2

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

161

1282

1.18

1.30

1.3

1.5

34798.85

61620.10

e6/l

1.57

744

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.77

1.30

1.0

2.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

585

1.27

1.0

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.77

1.27

2.0

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

2.45

1.26

13.0

13.2

640.00

151.00

e6/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

737

1.24

1.26

2.0

1.7

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

470

1.30

1.26

1.2

106.87

90.32

u/l

0.61

409

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.99

1.24

1.2

1.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

277

1.39

1.23

1.5

1.7

14.24

13.96

nmol/l

0.10

247

(3024263) Appearance of Synovial fluid

440

1.30

1.21

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

115

895

1.21

1.20

2.2

2.0

188.50

1753.25

u/ml

1.34

(3023511) Choriogonadotropin [Units/volume] in Urine

2.15

1.20

1.8

1.2

—

(3025577) Chromium [Mass/volume] in Blood

616

1.25

1.19

1.9

2.0

1.77

2.25

ug/l

1.52

512

(3048929) Epstein Barr virus Ab [Presence] in Serum

123

968

1.20

1.16

1.3

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

153

1228

1.17

1.15

1.7

4.27

4.56

mmol/24h

0.59

130

1006

(3034891) Synovial lining cells/100 cells in Synovial fluid

378

1.32

1.15

1.5

1.4

2.22

3.41

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

594

1.25

1.15

1.3

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

242

2010

1.13

1.15

1.5

—

(3026470) Cobalt [Mass/volume] in Blood

629

1.24

1.13

1.8

1.9

4.27

3.86

ug/l

0.22

572

(4212803) Bone marrow aspirate examination

107

0.44

1.12

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.80

1.12

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.65

1.11

6.5

5.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

613

0.77

1.10

1.7

1.6

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

204

1.43

1.10

1.4

1.3

36.71

30.84

0.41

134

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

456

1.28

1.09

1.3

1.2

24.88

28.68

u/l

0.34

383

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

173

1.47

1.09

1.1

1.2

233.61

273.84

pmol/l

0.49

118

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

701

1.22

1.08

1.1

185.43

696.42

iu/ml

0.56

112

(3001893) Eosinophils/100 leukocytes in Pleural fluid

358

1.31

1.07

1.3

1.4

0.78

2.65

4.20

296

(40768441) Liver Pathology biopsy report

416

1.29

1.07

1.1

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

116

0.49

1.05

1.0

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

147

1601

0.86

1.04

2.6

2.2

211.93

212.55

0.03

140

1501

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

385

3307

1.10

1.03

3.7

3.9

106.86

95.34

u/ml

0.12

369

3155

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

419

1.28

1.02

2.8

3.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

176

1.44

1.02

1.1

0.70

0.67

umol/24h

0.14

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

216

1800

1.13

1.00

2.0

2.1

3.66

3.64

g/l

0.06

203

1697

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.88

1.00

1.0

1.2

—

mmol/l

—

(3012565) Volume of 24 hour Urine

346

1.31

1.00

2.3

2.2

1617.30

1795.77

0.55

287

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

115

915

1.18

1.00

1.5

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

265

1.35

0.99

3.3

2.8

29.33

28.74

umol/l

0.13

200

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

108

1.57

0.98

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.80

0.96

1.1

1.6

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.80

0.96

1.2

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

109

1.55

0.95

2.1

86.62

133.37

nmol/l

1.66

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

156

1.45

0.93

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.58

0.92

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

587

1.22

0.92

1.0

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

123

993

1.17

0.92

1.7

1.9

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

310

1.31

0.91

1.1

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

103

1.55

0.91

1.1

0.21

0.90

u/ml

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.60

0.91

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

158

1.43

0.88

1.3

1.4

27.21

22.88

0.23

121

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

222

1.36

0.88

1.1

362.00

773.21

ng/l

0.57

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

396

1.26

0.87

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

396

1.26

0.87

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

677

1.20

0.87

1.5

1.3

45.71

58.85

titre

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

703

1.19

0.87

1.5

1.3

290.83

287.47

titre

0.01

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

160

1704

0.88

0.86

2.1

2.0

89.52

87.95

0.39

150

1623

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

338

1.28

0.86

1.3

11.64

336.61

ug/l

1.98

182

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

422

1.25

0.86

1.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

143

1175

1.15

0.86

1.6

1.8

18.49

23.57

ug/l

1.39

138

1140

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

397

1.26

0.86

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

183

1.39

0.86

1.3

1.5

8.10

9.55

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

628

1.20

0.84

1.3

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

525

0.79

0.84

1.0

45.30

45.86

ng/l

0.03

321

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

525

0.79

0.84

1.0

705.93

677.27

ng/l

0.13

312

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

525

0.79

0.84

1.0

340.57

337.91

ng/l

0.03

328

(3020491) Glucose [Moles/volume] in Blood

517

1.22

0.84

1.9

2.3

7.46

7.13

mmol/l

0.45

358

(37021550) Renin [Units/volume] in Plasma --upright

160

1.41

0.83

1.1

1.3

35.88

85.81

mu/l

1.71

114

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

136

1117

1.15

0.83

1.5

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

655

1.19

0.83

1.3

14.68

13.30

u/l

0.32

516

(21494755) Public health laboratory ask at order entry panel

813

0.83

1.2

1.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.54

0.83

18.1

12.5

4.95

5.30

mmol/l

0.28

(3028433) Virus identified in Specimen by Culture

225

1.34

0.82

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

751

1.18

0.82

1.6

51.73

49.29

nmol/l

0.40

701

(3047007) Chlamydophila sp Ab [Presence] in Serum

546

1.21

0.80

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.67

0.78

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

157

1661

0.89

0.78

1.9

1.8

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

260

1.30

0.78

1.1

12.33

13.00

iu/ml

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

131

1.44

0.77

1.0

1.2

80.57

80.58

0.00

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1029

0.86

0.77

1.7

1.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.77

0.0

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

395

1.24

0.77

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

395

1.24

0.77

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

713

1.17

0.77

1.3

1.1

284.47

294.00

u/ml

0.10

431

(3044290) Cell count panel - Cerebral spinal fluid

133

1099

1.14

0.76

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

396

1.24

0.75

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

337

1.26

0.75

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

473

1.21

0.75

1.4

1.5

6.82

7.13

u/l

0.07

378

(3036180) Methadone [Presence] in Urine

1.69

0.75

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.52

0.75

1.1

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.66

0.74

1.1

1.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

374

3268

1.08

0.74

2.3

1.14

1.16

g/l

0.02

286

2680

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

173

1.36

0.73

1.3

1.2

172.65

133.61

nmol/l

0.68

119

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

165

1.37

0.72

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

484

1.21

0.72

1.3

1.1

262.05

168.96

miu/ml

0.52

103

(3019897) Erythrocyte distribution width [Ratio] by Automated count

161

0.64

0.72

3.5

7.7

13.28

13.61

0.58

161

(3032868) Hemoglobin electrophoresis panel in Blood

1.96

0.71

1.2

1.5

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.73

0.70

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.51

0.70

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

249

1.28

0.69

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

110

0.60

0.68

1.0

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

144

1209

1.12

0.67

1.2

3.88

3.85

mmol/l

0.11

130

1113

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

632

5643

1.06

0.67

1.4

1.5

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

284

1.26

0.67

2.0

865.24

1844.26

u/ml

2.28

276

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

318

1.24

0.66

2.6

2.5

39.79

36.64

0.54

192

(3023410) Appearance of Cerebral spinal fluid

507

0.81

0.66

1.6

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.61

0.65

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

1.62

0.65

1.0

1.2

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

260

1.27

0.65

10.3

4.6

69.78

70.50

0.06

204

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

328

1.23

0.64

2.1

2.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

195

1672

1.10

0.63

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

472

0.82

0.62

1.3

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

472

0.82

0.62

1.3

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

138

1.36

0.61

1.2

1.1

—

(3020650) Glucose [Presence] in Urine

130

1.37

0.61

1.4

1.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

164

1397

1.11

0.61

1.2

1.3

579.56

579.90

mg/l

0.00

153

1305

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.2

—

374.03

—

(3000093) Morphology [Interpretation] in Blood Narrative

107

890

1.13

0.60

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

230

1.27

0.59

1.2

1.3

41.50

40.33

u/l

0.07

183

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

205

1.28

0.59

1.2

1.0

1.14

u/l

0.01

103

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

148

1.33

0.57

1.7

1.6

9.13

9.90

ug/l

0.36

148

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

609

0.85

0.57

1.2

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

767

6919

1.05

0.57

2.3

64.95

36.55

u/l

0.51

649

5838

(3012441) Differential panel - Pleural fluid

144

1225

1.11

0.56

1.4

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

317

1.22

0.56

1.0

1.1

—

(3001729) Color of Synovial fluid

1.43

0.56

1.2

1.8

—

(3044242) Glucose [Moles/volume] in Arterial blood

482

1.17

0.55

1.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

275

1.23

0.55

1.1

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.61

0.55

1.0

1.5

—

(3036048) Francisella tularensis Ab [Titer] in Serum

115

0.65

0.54

1.3

1.2

—

2096.00

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

166

1.30

0.54

1.0

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

250

1.24

0.54

1.4

1.5

72.10

92.71

umol/l

0.64

142

(3021387) Prolactin [Units/volume] in Serum or Plasma

579

1.15

0.54

1.8

283.31

330.64

mu/l

0.79

533

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.47

0.54

1.1

1.63

1.75

umol/24h

0.19

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

537

4812

1.05

0.53

5.5

7.1

24.38

24.46

mmol/l

0.22

508

4548

(3000034) Microalbumin [Mass/volume] in Urine

748

1.13

0.53

3.6

2.9

45.66

26.44

mg/l

0.56

555

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

105

1101

0.90

0.52

1.6

2.47

3.38

mg/l

0.79

842

(3042010) Triglyceride [Moles/volume] in Pleural fluid

143

1.32

0.51

1.2

2.06

1.88

mmol/l

—

(3006576) Bicarbonate [Moles/volume] in Blood

287

1.21

0.50

7.5

6.0

25.09

24.75

mmol/l

0.19

257

(3011288) Drugs identified in Urine by Screen method

119

1.34

0.50

1.8

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

169

1.28

0.49

1.0

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

550

1.15

0.49

1.4

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.39

0.49

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

375

1.18

0.48

1.0

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

289

1.20

0.48

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

289

1.20

0.48

1.1

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

187

1.26

0.47

1.1

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

171

1.26

0.46

1.0

1.1

—

(40768793) Breast Pathology biopsy report

185

1614

1.08

0.45

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

274

1.20

0.45

1.0

1.1

—

(40762814) Titanium [Mass/volume] in Blood

180

1.25

0.45

1.9

2.0

7.59

3.62

ug/l

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.40

0.45

1.1

1.3

—

(3011544) Albumin [Mass/volume] in Pleural fluid

105

1.34

0.44

1.2

1.1

16.90

16.62

g/l

0.05

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

130

1.30

0.44

1.0

1.3

85.42

78.39

0.49

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

339

3022

1.06

0.44

2.1

37.03

36.84

g/l

0.25

256

2483

(3035637) Corticotropin [Mass/volume] in Plasma

742

1.12

0.44

1.2

1.4

—

(40768795) Lymph node Pathology biopsy report

725

1.12

0.43

1.1

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.45

0.43

2.0

1.8

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.62

0.43

3.4

3.7

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

190

1.24

0.43

1.4

0.20

0.13

nmol/l

0.54

129

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.65

0.42

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.42

0.42

1.0

1.1

—

(3013762) Body weight Measured

0.00

0.41

0.0

1.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.52

0.41

1.0

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.28

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.41

0.0

1.1

—

50.13

—

(3051101) Glucose [Moles/volume] in Cord blood

174

1.24

0.41

4.1

5.9

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

107

1.32

0.40

1.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

149

1.26

0.40

7.4

7.7

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.33

0.40

1.4

1.1

5.41

6.21

mmol/l

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

167

1.24

0.39

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

187

1646

1.07

0.38

1.1

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.38

0.38

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

562

1.12

0.38

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

271

1.18

0.38

1.0

1.1

—

(40768806) Pleura Pathology biopsy report

140

1220

1.08

0.38

1.6

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

149

0.76

0.37

1.7

2.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

246

1.18

0.37

2.3

2.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.28

0.36

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.28

0.36

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

511

1.12

0.36

1.1

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

789

1.10

0.36

1.5

1.2

122.06

130.04

u/ml

0.30

168

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.45

0.36

1.0

1.1

0.45

0.53

u/ml

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

187

1.21

0.34

1.6

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.33

0.34

1.4

1.6

—

(3045788) Cell count panel - Pleural fluid

123

1072

1.08

0.34

1.3

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

275

1.16

0.33

2.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

275

1.16

0.33

2.1

2.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

111

1.27

0.33

1.1

1.8

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

258

1.17

0.33

2.8

2.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

215

1.18

0.32

1.5

0.44

0.40

ug/l

0.13

126

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

743

0.91

0.32

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

186

0.81

0.31

1.5

1.4

81.88

198.82

nmol/24h

0.99

186

(1001926) Buprenorphine [Presence] in Urine by Screen method

146

1.22

0.31

1.2

1.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.34

0.31

1.0

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

252

2259

1.05

0.31

1.3

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

252

2259

1.05

0.31

1.3

1.4

—

(3024932) HLA-DR beta [Type]

0.71

0.30

1.1

—

(21494434) Karyotype in Bone marrow

780

1.09

0.30

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

147

1.22

0.30

1.0

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

435

0.89

0.30

2.7

2.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

332

1.13

0.29

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

350

1.13

0.29

1.0

1.1

11.15

11.91

nmol/l

—

(3034426) Prothrombin time (PT)

153

0.80

0.29

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.28

0.28

1.2

1.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

132

0.78

0.28

1.0

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

383

0.88

0.28

1.1

1.2

9.88

9.52

mmol/l

0.20

365

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.27

0.28

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

263

1.14

0.27

1.0

1.1

311.63

300.97

mg/l

0.12

230

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

754

0.92

0.26

1.1

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.70

0.26

1.0

—

(40765096) Chromosome analysis panel by Banding

241

0.86

0.25

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

124

1.21

0.25

2.5

2.9

1.00

0.46

u/field

0.78

124

(3014891) Appearance of Pleural fluid

194

1.16

0.25

1.3

1.2

—

(3047189) Immunofixation for 24 hour Urine

439

0.90

0.25

1.3

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

134

1190

1.06

0.25

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

734

1.08

0.25

1.3

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

133

1.20

0.25

1.8

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

110

971

1.07

0.25

3.3

—

(3016879) Cocaine [Presence] in Urine

168

1.18

0.25

1.2

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

142

1.19

0.24

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

392

3572

1.03

0.24

2.3

2.6

0.38

0.35

u/ml

0.85

240

2029

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.70

0.24

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

329

1.11

0.24

1.1

—

(3025130) Human papilloma virus identified in Specimen

383

1.10

0.23

1.6

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

169

1.17

0.23

1.2

1.4

1.52

1.57

g/l

0.60

169

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

239

0.86

0.23

1.5

1.8

5769.38

20184.62

e6/l

1.00

133

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.31

0.23

1.0

1.1

379.00

742.83

u/l

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

132

1177

1.05

0.22

1.3

99.71

23.64

e6/l

0.42

102

920

(3002619) Bacteria identified in Specimen by Culture

161

1.17

0.22

1.2

—

(3044007) Cell count panel - Peritoneal fluid

218

0.86

0.22

1.6

1.7

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

132

1178

1.05

0.22

1.5

1.4

745.53

890.73

e6/l

0.18

109

972

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

109

1.21

0.22

5.9

2.9

35.66

40.09

umol/l

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

237

0.87

0.21

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

570

0.92

0.21

1.2

1.1

116.29

115.46

0.05

486

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.17

0.21

1.0

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.17

0.21

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

102

906

1.06

0.20

1.2

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

782

0.94

0.20

1.1

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.20

0.0

1.3

—

8.80

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.0

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.12

—

(3008536) Aspergillus sp Ab [Presence] in Serum

146

0.84

0.20

2.1

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

330

3192

0.97

0.20

2.3

3.0

9151.37

1808.58

u/ml

0.43

270

2678

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

266

2582

0.97

0.20

2.2

0.00

g/l

-0.00

243

2307

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.17

0.19

1.2

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

280

1.11

0.19

1.2

1.5

64.18

60.00

0.30

240

(3013293) Extractable nuclear Ab [Presence] in Serum

1.22

0.18

1.8

1.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

508

1.07

0.18

1.1

—

3.15

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.22

0.18

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

1.22

0.18

1.3

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.20

0.18

6.3

4.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

114

0.82

0.18

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.17

0.18

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.15

0.17

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

213

0.88

0.17

1.5

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

496

0.93

0.17

1.1

1.2

145.00

129.66

titre

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

794

1.05

0.17

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.75

0.17

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

166

1.13

0.16

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

166

1.13

0.16

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

166

1.13

0.16

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

166

1.13

0.16

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

175

1.13

0.16

1.2

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

182

0.88

0.16

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

430

1.07

0.15

1.7

1.9

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

158

1.13

0.15

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.14

0.15

1.0

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.10

0.15

4.3

2.4

—

70.83

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.81

0.14

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.81

0.14

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

655

0.95

0.14

1.5

1.2

4.35

4.83

u/ml

0.14

280

(3022689) Creatine [Moles/volume] in Urine

177

1.12

0.14

1.6

1.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

673

0.95

0.14

2.0

1.7

5.17

4.75

mg/l

0.23

628

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

838

1.04

0.13

1.0

—

(3027008) Opiates [Presence] in Urine

178

1.11

0.13

1.2

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

178

1.11

0.13

2.1

2.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

274

2631

0.98

0.12

2.2

0.00

g/l

1.25

243

2318

(3028300) Cannabinoids [Presence] in Urine

179

1.10

0.12

1.2

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

171

1.10

0.11

1.1

1.2

5.31

3.08

u/l

—

(3035320) C reactive protein [Mass/volume] in Body fluid

542

0.95

0.10

3.3

2.6

—

(3036489) Thrombin time

247

2367

0.98

0.10

1.9

1.8

22.49

22.00

0.28

219

2149

(3027944) Amphetamines [Presence] in Urine

172

1.09

0.10

1.2

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

224

0.92

0.10

1.1

1.0

0.04

0.32

u/ml

—

126

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

102

988

0.97

0.09

3.2

3.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

540

0.96

0.09

1.1

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.04

0.09

1.2

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.04

0.09

1.2

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

295

2728

1.02

0.09

3.7

3.5

—

(3006245) CD3-CD19+ cells/100 cells in Blood

173

1.09

0.09

1.9

1.8

9.53

10.43

0.09

150

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.13

0.09

1.0

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.13

0.09

4.7

4.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

394

1.05

0.08

1.3

1.4

43.37

39.64

iu/l

0.24

338

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1.03

0.08

1.0

2.6

—

2.96

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

284

1.06

0.08

1.1

51.04

43.82

mg/l

0.39

245

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.04

0.08

1.0

1.2

7.29

10.29

u/l

—

(40758292) HTLV I+II Ab panel - Serum

0.83

0.07

1.2

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

184

1.07

0.07

1.6

1.3

151.90

140.23

pmol/l

0.22

184

(3009871) Measles virus Ab [Titer] in Serum

1.02

0.07

1.8

1.7

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.02

0.07

1.4

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

0.85

0.07

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

153

0.92

0.06

1.1

—

(3051651) Icteric interference index of Serum or Plasma

506

0.97

0.06

3.1

3.7

—

(3024471) HLA-A [Type]

0.88

0.06

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

259

1.05

0.06

1.4

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

510

1.03

0.06

1.8

1.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

200

0.94

0.06

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

112

1.09

0.05

1.1

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

362

1.04

0.05

1.0

—

(3000060) B lymphocytes [#/volume] in Blood

103

1.10

0.05

2.5

1.6

75.00

1580.45

e6/l

—

(4281824) Cell count and differential, peritoneal fluid

800

1.02

0.05

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

567

1.03

0.05

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

369

0.97

0.04

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

206

1.05

0.04

2.3

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

262

1.04

0.04

2.1

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

225

1.04

0.04

1.3

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

123

1.07

0.03

4.7

3.8

54.21

55.02

u/l

0.02

116

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

244

1.04

0.03

1.1

—

(3024928) Oxygen saturation in Venous blood

189

1760

1.01

0.03

2.5

2.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

394

1.03

0.03

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.08

0.02

2.1

1.5

—

(3015183) Erythrocyte sedimentation rate

120

0.94

0.02

1.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

290

0.97

0.02

1.3

1.2

6.10

6.24

mmol/l

0.21

270

(3008401) Mugwort IgE Ab [Units/volume] in Serum

308

0.98

0.01

1.0

0.45

1.10

u/ml

—

123

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

119

0.95

0.01

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

316

0.98

0.00

1.0

0.96

1.73

u/ml

—

130

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

436

1.01

0.00

2.1

2.2

42.73

128.22

ug/min

0.84

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

101

1.02

0.00

5.9

7.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

121

1.01

0.00

6.2

7.6

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

117

0.96

0.00

1.0

1.5

—

13.72

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

100

1.03

0.00

1.0

1.2

31.60

47.38

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

673

1.01

0.00

1.4

1.2

6.47

5.58

u/ml

0.13

206

(3011648) Oxygen content in Venous blood

558

0.99

0.00

1.8

1.6

10.93

10.19

0.76

558

(3024666) Lithium [Moles/volume] in Serum or Plasma

122

1.00

0.00

13.8

10.6

0.62

0.65

mmol/l

0.19

112

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

135

0.97

0.00

1.0

—

(3033799) Differential panel - Peritoneal fluid

245

1.00

0.00

1.4

1.7

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

129

1.02

0.00

1.2

1.3

34.76

119.86

ug/l

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

501

0.99

0.00

1.0

1.1

10.97

2.87

u/ml

0.78

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.02

0.00

1.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

265

0.99

0.00

1.5

1.9

2095.14

4262.98

e6/l

0.29

178

(3032773) Endomysium IgG Ab [Titer] in Serum

419

1.01

0.00

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

299

2808

1.00

0.00

2.2

0.08

0.04

g/l

0.36

266

2486

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

369

0.99

0.00

1.1

0.70

0.78

u/ml

0.06

192

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

164

1.03

0.00

1.2

29.17

22.59

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

-0.00

0.0

2.2

—

(3021374) Sirolimus [Mass/volume] in Blood

0.00

-0.00

0.0

6.7

—

6.35

—

(3009992) Blasts/100 cells in Bone marrow

0.00

-0.00

0.0

2.0

—

5.80

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.00

-0.00

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.98

-0.00

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.87

-0.00

1.0

1.4

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3042517) Benzodiazepines panel - Urine

0.00

-0.00

0.0

1.4

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

-0.00

0.0

2.1

—

(3042733) HLA Ab [Presence] in Serum

0.92

-0.00

6.1

4.5

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.00

-0.00

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

0.91

-0.00

1.7

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.98

-0.00

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.87

-0.00

1.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.00

-0.00

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.2

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint DRY_AMD and mortality.

Females

Parameter	HR [95% CI]	p-value
DRY_AMD	0.971 [0.89, 1.06]	0.514
Birth year	0.994 [0.99, 1.0]	0.12

During the follow-up period (1.1.1998 — 31.12.2019), 18068 out of 41213 females with DRY_AMD died.

Males

Parameter	HR [95% CI]	p-value
DRY_AMD	1.016 [0.91, 1.13]	0.779
Birth year	0.987 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 10705 out of 22693 males with DRY_AMD died.

Mortality risk

Mortality risk for people of age

years, who have DRY_AMD.

N-year risk	Females	Males
1	0.089%	0.153%
5	0.571%	1.022%
10	1.375%	2.718%
15	2.611%	5.53%
20	4.548%	9.433%

Relationships between endpoints

↥

Index endpoint: DRY_AMD – Dry age-related macular degeneration (includes geographic atrophy)

GWS hits: 25

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Dry age-related macular degeneration (includes geographic atrophy)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints